(506621, 'HP:0003559', 'Muscle hyperirritability', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506622, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506623, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506624, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506625, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020240', 'increased skeletal muscle cell apoptosis', 0.42424242424242425, 9.83016599489719, 2.0421492238278343, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506626, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011952', 'decreased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506627, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506628, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506629, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506630, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506631, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506632, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506633, 'HP:0003559', 'Muscle hyperirritability', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506634, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506635, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003725', 'increased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506636, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506637, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506638, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506639, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506640, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506641, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506642, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506643, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506644, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506645, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506646, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506647, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002634', 'abnormal sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506648, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003464', 'abnormal single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506649, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506650, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506651, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506652, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005043', 'defective assembly of class II molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506653, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506654, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506655, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506656, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004143', 'muscle hypertonia', 0.56, 9.83016599489719, 2.346250829971601, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506657, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000740', 'impaired smooth muscle contractility', 0.5384615384615384, 9.83016599489719, 2.3006882241939346, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506658, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506659, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506660, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506661, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506662, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005000', 'abnormal immune tolerance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506663, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506664, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506665, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506666, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506667, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011938', 'prolonged PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506668, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506669, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506670, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506671, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506672, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506673, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010553', 'prolonged HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506674, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506675, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506676, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002841', 'impaired skeletal muscle contractility', 0.5384615384615384, 9.83016599489719, 2.3006882241939346, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506677, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020418', 'increased cardiac muscle relaxation', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506678, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506679, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506680, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009062', 'impaired lectin complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506681, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506682, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012006', 'abnormal hippocampus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506683, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506684, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031402', 'decreased muscle fatigability', 0.5833333333333334, 9.83016599489719, 2.3946322258383144, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506685, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506686, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030147', 'abnormal digastric muscle physiology', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506687, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506688, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506689, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506690, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506691, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000729', 'abnormal myogenesis', 0.40625, 6.010646887362416, 1.5626340896035071, 'UPHENO:0002816', 'abnormal musculature'),
(506692, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506693, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506694, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020381', 'muscle gating pore current', 0.56, 9.83016599489719, 2.346250829971601, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506695, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506696, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506697, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020241', 'decreased skeletal muscle cell apoptosis', 0.42424242424242425, 9.83016599489719, 2.0421492238278343, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506698, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506699, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506700, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008748', 'abnormal central T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506701, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008747', 'abnormal T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506702, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506703, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506704, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020001', 'decreased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506705, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506706, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005044', 'sepsis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506707, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506708, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506709, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506710, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506711, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506712, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506713, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506714, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012565', 'perivasculitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506715, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011994', 'increased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506716, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002409', 'decreased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506717, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506718, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506719, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506720, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506721, 'HP:0003559', 'Muscle hyperirritability', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506722, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506723, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005600', 'increased ventricle muscle contractility', 0.4375, 9.83016599489719, 2.0738123402968553, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506724, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506725, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506726, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001835', 'abnormal antigen presentation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506727, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020239', 'abnormal skeletal muscle cell apoptosis', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506728, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005005', 'abnormal self tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506729, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003290', 'intestinal hypoperistalsis', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506730, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506731, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013625', 'increased femur yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506732, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506733, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031170', 'abnormal vasculature physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506734, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506735, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506736, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001790', 'abnormal immune system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506737, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506738, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002499', 'chronic inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506739, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506740, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506741, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.5833333333333334, 9.83016599489719, 2.3946322258383144, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506742, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506743, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506744, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506745, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506746, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506747, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506748, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001912', 'increased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506749, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506750, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506751, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506752, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506753, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506754, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506755, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506756, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506757, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009046', 'muscle twitch', 0.5833333333333334, 9.83016599489719, 2.3946322258383144, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506758, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506759, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506760, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506761, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506762, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506763, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506764, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506765, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506766, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506767, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506768, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506769, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506770, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506771, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506772, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010514', 'fragmented QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506773, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506774, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506775, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506776, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506777, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506778, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506779, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506780, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506781, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506782, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002578', 'impaired ability to fire action potentials', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506783, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506784, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005001', 'abnormal clonal deletion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506785, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506786, 'HP:0003559', 'Muscle hyperirritability', 'MP:0021009', 'abnormal synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506787, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506788, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506789, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506790, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506791, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506792, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003091', 'abnormal cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506793, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004037', 'increased muscle relaxation', 0.56, 9.83016599489719, 2.346250829971601, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506794, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001837', 'defective assembly of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506795, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506796, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506797, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002406', 'increased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506798, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506799, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506800, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506801, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003466', 'decreased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506802, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008558', 'abnormal interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506803, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506804, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009045', 'muscle tetany', 0.5384615384615384, 9.83016599489719, 2.3006882241939346, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506805, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506806, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003473', 'decreased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506807, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506808, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001844', 'autoimmune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506809, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506810, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506811, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506812, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506813, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506814, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506815, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506816, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506817, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506818, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506819, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003547', 'abnormal pulmonary pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506820, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506821, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506822, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506823, 'HP:0003559', 'Muscle hyperirritability', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506824, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030143', 'facial muscle spasm', 0.4375, 9.83016599489719, 2.0738123402968553, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506825, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506826, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506827, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506828, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012382', 'abnormal blood cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506829, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506830, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005088', 'increased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506831, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506832, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004039', 'abnormal cardiac cell glucose uptake', 0.4117647058823529, 9.83016599489719, 2.011893488647833, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506833, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006080', 'brain ischemia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506834, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506835, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004510', 'myositis', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506836, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506837, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506838, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506839, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506840, 'HP:0003559', 'Muscle hyperirritability', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506841, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506842, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506843, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506844, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506845, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012011', 'febrile seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506846, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506847, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506848, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506849, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506850, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506851, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005595', 'abnormal vascular smooth muscle physiology', 0.4117647058823529, 9.83016599489719, 2.011893488647833, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506852, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506853, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506854, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006109', 'fibrillation', 0.4375, 9.83016599489719, 2.0738123402968553, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506855, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506856, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506857, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506858, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030126', 'torticollis', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506859, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506860, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506861, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506862, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506863, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506864, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002106', 'abnormal muscle physiology', 0.6086956521739131, 9.83016599489719, 2.446135585212269, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506865, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000948', 'nonconvulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506866, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506867, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506868, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506869, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005025', 'abnormal response to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506870, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506871, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002500', 'granulomatous inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506872, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506873, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506874, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506875, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506876, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506877, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506878, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506879, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506880, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506881, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010513', 'abnormal ventricular activation time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506882, 'HP:0003559', 'Muscle hyperirritability', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506883, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003476', 'decreased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506884, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009410', 'abnormal skeletal muscle satellite cell proliferation', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506885, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506886, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506887, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506888, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506889, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003468', 'increased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506890, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506891, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506892, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003481', 'decreased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506893, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506894, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506895, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002064', 'seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506896, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506897, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030132', 'periodontium inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506898, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506899, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506900, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506901, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506902, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506903, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506904, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506905, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506906, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506907, 'HP:0003559', 'Muscle hyperirritability', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506908, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010368', 'abnormal lymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506909, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506910, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506911, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.5185185185185185, 9.83016599489719, 2.2576809137841445, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506912, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506913, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506914, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506915, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506916, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506917, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003465', 'increased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506918, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506919, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506920, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506921, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002328', 'abnormal airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506922, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506923, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005087', 'decreased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506924, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506925, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506926, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506927, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005598', 'decreased ventricle muscle contractility', 0.42424242424242425, 9.83016599489719, 2.0421492238278343, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506928, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506929, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506930, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506931, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506932, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506933, 'HP:0003559', 'Muscle hyperirritability', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506934, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004130', 'abnormal muscle cell glucose uptake', 0.4827586206896552, 9.83016599489719, 2.178439206598825, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506935, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506936, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506937, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506938, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004145', 'abnormal muscle electrophysiology', 0.5833333333333334, 9.83016599489719, 2.3946322258383144, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506939, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506940, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002472', 'impaired complement alternative pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506941, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008543', 'atrial fibrillation', 0.42424242424242425, 9.83016599489719, 2.0421492238278343, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506942, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506943, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506944, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506945, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506946, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506947, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506948, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004085', 'abnormal heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506949, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506950, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506951, 'HP:0003559', 'Muscle hyperirritability', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506952, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506953, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506954, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506955, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004142', 'abnormal muscle tone', 0.5833333333333334, 9.83016599489719, 2.3946322258383144, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506956, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506957, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506958, 'HP:0003559', 'Muscle hyperirritability', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506959, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506960, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010519', 'atrioventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506961, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506962, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506963, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000747', 'muscle weakness', 0.45161290322580644, 9.83016599489719, 2.106995444738103, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506964, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506965, 'HP:0003559', 'Muscle hyperirritability', 'MP:0005323', 'dystonia', 0.4666666666666667, 9.83016599489719, 2.14182417523444, 'UPHENO:0002320', 'abnormality of muscle organ physiology'),
(506966, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506967, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506968, 'HP:0003559', 'Muscle hyperirritability', 'MP:0002420', 'abnormal adaptive immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506969, 'HP:0003559', 'Muscle hyperirritability', 'MP:0000343', 'abnormal response to cardiac infarction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506970, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003777', 'lip inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506971, 'HP:0003559', 'Muscle hyperirritability', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506972, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506973, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003471', 'abnormal summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506974, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506975, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506976, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506977, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506978, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506979, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506980, 'HP:0003559', 'Muscle hyperirritability', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506981, 'HP:0003559', 'Muscle hyperirritability', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506982, 'HP:0003559', 'Muscle hyperirritability', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506983, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506984, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001337', 'dry eyes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506985, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020155', 'enhanced humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506986, 'HP:0003559', 'Muscle hyperirritability', 'MP:0003726', 'decreased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506987, 'HP:0003559', 'Muscle hyperirritability', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506988, 'HP:0003559', 'Muscle hyperirritability', 'MP:0020218', 'abnormal tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506989, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506990, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506991, 'HP:0003559', 'Muscle hyperirritability', 'MP:0013806', 'encephalopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506992, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506993, 'HP:0003559', 'Muscle hyperirritability', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506994, 'HP:0003559', 'Muscle hyperirritability', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506995, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506996, 'HP:0003559', 'Muscle hyperirritability', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506997, 'HP:0003559', 'Muscle hyperirritability', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506998, 'HP:0003559', 'Muscle hyperirritability', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(506999, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0003665', 'endophthalmitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507000, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0030933', 'hyphema', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507001, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020980', 'increased FO-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507002, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0014157', 'alacrima', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507003, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012151', 'increased a-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507004, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006252', 'lateral rectus palsy', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507005, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020979', 'decreased FO-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507006, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006149', 'decreased visual acuity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507007, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0013479', 'scleritis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507008, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012030', 'abnormal a-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507009, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020962', 'increased c-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507010, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0005257', 'abnormal intraocular pressure', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507011, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0001999', 'photosensitivity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507012, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020860', 'abnormal cornea physiology', 0.5142857142857142, 8.795504987450572, 2.126829227976374, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507013, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020958', 'abnormal c-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507014, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020974', 'abnormal FO-wave shape', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507015, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0013466', 'keratoconjunctivitis sicca', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507016, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012149', 'decreased b-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507017, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0010749', 'absent visual evoked potential', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507018, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0001852', 'conjunctivitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507019, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0003100', 'myopia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507020, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012033', 'abnormal ERG implicit time', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507021, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012037', 'abnormal b-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507022, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006147', 'monocular blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507023, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006145', 'legal blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507024, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020218', 'abnormal tear production', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507025, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0001851', 'eye inflammation', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507026, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012153', 'increased b-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507027, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020961', 'abnormal c-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507028, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006203', 'eye hemorrhage', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507029, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020220', 'decreased tear production', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507030, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0003011', 'delayed dark adaptation', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507031, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012035', 'abnormal b-wave shape', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507032, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0008793', 'abnormal lens epithelium apoptosis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507033, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0013480', 'cyclitis', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507034, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012050', 'decreased susceptilbility to retina ischemic injury', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507035, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0004021', 'abnormal rod electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507036, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0011275', 'abnormal behavioral response to light', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507037, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0003101', 'high myopia', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507038, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012031', 'abnormal b-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507039, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006201', 'vitreous body inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507040, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012036', 'abnormal a-wave latency', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507041, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0005260', 'ocular hypotension', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507042, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012034', 'abnormal a-wave shape', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507043, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507044, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012032', 'abnormal ERG latency', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507045, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507046, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006072', 'abnormal retina apoptosis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507047, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012147', 'increased a-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507048, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0005515', 'uveitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507049, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006194', 'keratoconjunctivitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507050, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0008144', 'nyctalopia', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507051, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006229', 'iris inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507052, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006156', 'abnormal visual pursuit', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507053, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0011832', 'abnormal visual acuity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507054, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012146', 'increased b-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507055, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012144', 'decreased b-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507056, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0013145', 'eye discharge', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507057, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507058, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006251', 'eyelid apraxia', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507059, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020976', 'increased FO-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507060, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0005551', 'abnormal eye electrophysiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507061, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0001389', 'abnormal eye movement', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507062, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0001848', 'choroid inflammation', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507063, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0010748', 'abnormal visual evoked potential', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507064, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020960', 'increased c-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507065, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0008145', 'hemeralopia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507066, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507067, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507068, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507069, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012145', 'increased a-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507070, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006153', 'hypermetropia', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507071, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006224', 'oculomotor apraxia', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507072, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020439', 'absent b-wave', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507073, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020861', 'abnormal corneal wound healing', 0.46153846153846156, 8.795504987450572, 2.014811117787919, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507074, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006152', 'tunnel vision', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507075, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012152', 'decreased a-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507076, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012148', 'decreased a-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507077, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006190', 'retina ischemia', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507078, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0002090', 'abnormal vision', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507079, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0014132', 'abnormal tear film physiology', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507080, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0001337', 'dry eyes', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507081, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0005253', 'abnormal eye physiology', 0.5151515151515151, 8.795504987450572, 2.1286187354263024, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507082, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0001313', 'increased incidence of corneal inflammation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507083, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0013478', 'corneal limbitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507084, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012154', 'decreased b-wave latency', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507085, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020959', 'decreased c-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507086, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012038', 'abnormal a-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507087, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507088, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0002001', 'blindness', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507089, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0003096', 'increased corneal light-scattering', 0.5, 8.795504987450572, 2.097081899622732, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507090, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507091, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012040', 'abnormal c-wave shape', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507092, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006150', 'double vision', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507093, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0005251', 'blepharitis', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507094, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012150', 'increased b-wave implicit time', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507095, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020963', 'decreased c-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507096, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0031497', 'increased visual acuity', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507097, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0005258', 'ocular hypertension', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507098, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0004022', 'abnormal cone electrophysiology', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507099, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012143', 'decreased a-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507100, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006148', 'binocular blindness', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507101, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012049', 'increased susceptilbility to retina ischemic injury', 0.4473684210526316, 8.795504987450572, 1.9836408895251956, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507102, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0008795', 'abnormal lens fiber apoptosis', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507103, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020219', 'increased tear production', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507104, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0020977', 'decreased FO-wave amplitude', 0.4594594594594595, 8.795504987450572, 2.0102681331620964, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507105, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0006157', 'palsy of the eye', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507106, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0013468', 'chromodacryorrhea', 0.4857142857142857, 8.795504987450572, 2.066906486146868, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507107, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0002638', 'abnormal pupillary reflex', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507108, 'HP:0007932', 'Bilateral congenital mydriasis', 'MP:0012039', 'abnormal b-wave implicit time', 0.4722222222222222, 8.795504987450572, 2.0379972793751584, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(507109, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012377', 'decreased erythrocyte potassium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507110, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0013658', 'abnormal myeloid cell morphology', 0.4722222222222222, 9.052558416233639, 2.0675636029177746, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(507111, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010067', 'increased red blood cell distribution width', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507112, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0000358', 'abnormal cell morphology', 0.45161290322580644, 6.121988824155609, 1.6627594974598268, 'UPHENO:0084928', 'abnormal cell morphology'),
(507113, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0004230', 'abnormal embryonic erythrocyte morphology', 0.4090909090909091, 10.15319077934013, 2.03803288641123, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(507114, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012373', 'abnormal erythrocyte magnesium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507115, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0013656', 'abnormal hematopoietic cell morphology', 0.45714285714285713, 7.94655706237675, 1.9059674183846, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(507116, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0001588', 'abnormal hemoglobin', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507117, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0011180', 'abnormal hematopoietic cell number', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(507118, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012378', 'increased erythrocyte potassium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507119, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010176', 'dacryocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507120, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0009547', 'elliptocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507121, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012381', 'increased erythrocyte sodium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507122, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012397', 'abnormal nucleated erythrocyte cell number', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507123, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010074', 'stomatocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507124, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0002608', 'increased hematocrit', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507125, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0002642', 'anisocytosis', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507126, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0002596', 'abnormal hematocrit', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507127, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010178', 'increased number of Howell-Jolly bodies', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507128, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012376', 'abnormal erythrocyte potassium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507129, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012375', 'increased erythrocyte magnesium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507130, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0005641', 'increased mean corpuscular hemoglobin concentration', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507131, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0013707', 'abnormal hematopoietic precursor cell morphology', 0.43243243243243246, 7.94655706237675, 1.853739194155074, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(507132, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010696', 'increased siderocyte number', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507133, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0005640', 'abnormal mean corpuscular hemoglobin concentration', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507134, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0009568', 'abnormal red blood cell deformability', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507135, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010068', 'decreased red blood cell distribution width', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507136, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012380', 'decreased erythrocyte sodium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507137, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010177', 'acanthocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507138, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0013661', 'abnormal myeloid cell number', 0.40476190476190477, 9.052558416233639, 1.9141919411394301, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(507139, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012379', 'abnormal erythrocyte sodium ion content', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507140, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010066', 'abnormal red blood cell distribution width', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507141, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0003902', 'abnormal cell mass', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(507142, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0009840', 'abnormal foam cell morphology', 0.42424242424242425, 6.121988824155609, 1.6115853622891974, 'UPHENO:0084928', 'abnormal cell morphology'),
(507143, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0004808', 'abnormal hematopoietic stem cell morphology', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(507144, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012398', 'decreased nucleated erythrocyte cell number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507145, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0009395', 'increased nucleated erythrocyte cell number', 0.41304347826086957, 10.352905980535489, 2.0678975545969718, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507146, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0002877', 'abnormal melanocyte morphology', 0.4117647058823529, 6.121988824155609, 1.5877087036334738, 'UPHENO:0084928', 'abnormal cell morphology'),
(507147, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0011171', 'increased number of Heinz bodies', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507148, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012372', 'abnormal erythrocyte ion content', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507149, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0013702', 'abnormal megakaryocyte-erythroid progenitor cell morphology', 0.425, 9.052558416233639, 1.9614630577452374, 'UPHENO:0085068', 'abnormal myeloid cell morphology'),
(507150, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0002424', 'abnormal reticulocyte morphology', 0.45, 10.15319077934013, 2.1375069241298514, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(507151, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0010175', 'leptocytosis', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507152, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0012374', 'decreased erythrocyte magnesium ion content', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507153, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0002447', 'abnormal erythrocyte morphology', 0.4318181818181818, 10.352905980535489, 2.114372965455578, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507154, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0005642', 'decreased mean corpuscular hemoglobin concentration', 0.40425531914893614, 10.352905980535489, 2.0457803673122643, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507155, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0013657', 'abnormal blood cell morphology', 0.41025641025641024, 7.94655706237675, 1.8055818935480081, 'UPHENO:0085118', 'abnormal hematopoietic cell morphology'),
(507156, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0002814', 'hyperchromasia', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507157, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0013659', 'abnormal erythroid lineage cell morphology', 0.47368421052631576, 10.15319077934013, 2.1930358315893517, 'UPHENO:0088170', 'abnormal erythroid lineage cell morphology'),
(507158, 'HP:0010970', 'Blood group antigen abnormality', 'MP:0005097', 'polychromatophilia', 0.4222222222222222, 10.352905980535489, 2.090747945009017, 'UPHENO:0088162', 'abnormal erythrocyte morphology'),
(507159, 'HP:0002518', 'Abnormal periventricular white matter morphology', 'MP:0020141', 'decreased brain external capsule size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(507160, 'HP:0002518', 'Abnormal periventricular white matter morphology', 'MP:0020140', 'increased brain external capsule size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(507161, 'HP:0100790', 'Hernia', 'MP:0012260', 'encephalomeningocele', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507162, 'HP:0100790', 'Hernia', 'MP:0003384', 'abnormal ventral body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507163, 'HP:0100790', 'Hernia', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507164, 'HP:0100790', 'Hernia', 'MP:0013121', 'testicular swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507165, 'HP:0100790', 'Hernia', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507166, 'HP:0100790', 'Hernia', 'MP:0001726', 'abnormal allantois morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507167, 'HP:0100790', 'Hernia', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507168, 'HP:0100790', 'Hernia', 'MP:0004134', 'abnormal chest morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507169, 'HP:0100790', 'Hernia', 'MP:0002113', 'abnormal skeleton development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507170, 'HP:0100790', 'Hernia', 'MP:0000130', 'abnormal trabecular bone morphology', 0.4166666666666667, 7.212684573300959, 1.7335758532222925, 'UPHENO:0002712', 'abnormal connective tissue'),
(507171, 'HP:0100790', 'Hernia', 'MP:0014143', 'decreased body fat mass', 0.4166666666666667, 7.212684573300959, 1.7335758532222925, 'UPHENO:0002712', 'abnormal connective tissue'),
(507172, 'HP:0100790', 'Hernia', 'MP:0014134', 'abnormal embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507173, 'HP:0100790', 'Hernia', 'MP:0003300', 'gastrointestinal ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507174, 'HP:0100790', 'Hernia', 'MP:0020520', 'whitened brown adipose tissue morphology', 0.43478260869565216, 7.212684573300959, 1.7708613199453755, 'UPHENO:0002712', 'abnormal connective tissue'),
(507175, 'HP:0100790', 'Hernia', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507176, 'HP:0100790', 'Hernia', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507177, 'HP:0100790', 'Hernia', 'MP:0020973', 'abnormal gland development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507178, 'HP:0100790', 'Hernia', 'MP:0010924', 'abnormal osteoid morphology', 0.4166666666666667, 7.212684573300959, 1.7335758532222925, 'UPHENO:0002712', 'abnormal connective tissue'),
(507179, 'HP:0100790', 'Hernia', 'MP:0003861', 'abnormal nervous system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507180, 'HP:0100790', 'Hernia', 'MP:0002111', 'abnormal tail morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507181, 'HP:0100790', 'Hernia', 'MP:0031377', 'ambiguous external genitalia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507182, 'HP:0100790', 'Hernia', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507183, 'HP:0100790', 'Hernia', 'MP:0005499', 'abnormal olfactory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507184, 'HP:0100790', 'Hernia', 'MP:0001983', 'abnormal olfactory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507185, 'HP:0100790', 'Hernia', 'MP:0000462', 'abnormal digestive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507186, 'HP:0100790', 'Hernia', 'MP:0005508', 'abnormal skeleton morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507187, 'HP:0100790', 'Hernia', 'MP:0013133', 'pale limbs', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507188, 'HP:0100790', 'Hernia', 'MP:0002970', 'abnormal white adipose tissue morphology', 0.45454545454545453, 7.212684573300959, 1.8106609257020134, 'UPHENO:0002712', 'abnormal connective tissue'),
(507189, 'HP:0100790', 'Hernia', 'MP:0000266', 'abnormal heart morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507190, 'HP:0100790', 'Hernia', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507191, 'HP:0100790', 'Hernia', 'MP:0000010', 'abnormal abdominal fat pad morphology', 0.4166666666666667, 7.212684573300959, 1.7335758532222925, 'UPHENO:0002712', 'abnormal connective tissue'),
(507192, 'HP:0100790', 'Hernia', 'MP:0012320', 'abnormal body fat mass', 0.43478260869565216, 7.212684573300959, 1.7708613199453755, 'UPHENO:0002712', 'abnormal connective tissue'),
(507193, 'HP:0100790', 'Hernia', 'MP:0006281', 'abnormal tail development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507194, 'HP:0100790', 'Hernia', 'MP:0020982', 'abnormal skin adnexa development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507195, 'HP:0100790', 'Hernia', 'MP:0000428', 'abnormal craniofacial morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507196, 'HP:0100790', 'Hernia', 'MP:0005459', 'decreased percent body fat/body weight', 0.45454545454545453, 7.212684573300959, 1.8106609257020134, 'UPHENO:0002712', 'abnormal connective tissue'),
(507197, 'HP:0100790', 'Hernia', 'MP:0013332', 'peliosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507198, 'HP:0100790', 'Hernia', 'MP:0000752', 'dystrophic muscle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507199, 'HP:0100790', 'Hernia', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4166666666666667, 7.212684573300959, 1.7335758532222925, 'UPHENO:0002712', 'abnormal connective tissue'),
(507200, 'HP:0100790', 'Hernia', 'MP:0013119', 'abdomen swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507201, 'HP:0100790', 'Hernia', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507202, 'HP:0100790', 'Hernia', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507203, 'HP:0100790', 'Hernia', 'MP:0010233', 'hairless tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507204, 'HP:0100790', 'Hernia', 'MP:0013124', 'mouth swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507205, 'HP:0100790', 'Hernia', 'MP:0002925', 'abnormal cardiovascular development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507206, 'HP:0100790', 'Hernia', 'MP:0013118', 'swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507207, 'HP:0100790', 'Hernia', 'MP:0003632', 'abnormal nervous system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507208, 'HP:0100790', 'Hernia', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507209, 'HP:0100790', 'Hernia', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507210, 'HP:0100790', 'Hernia', 'MP:0012514', 'pectus excavatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507211, 'HP:0100790', 'Hernia', 'MP:0014142', 'increased body fat mass', 0.4166666666666667, 7.212684573300959, 1.7335758532222925, 'UPHENO:0002712', 'abnormal connective tissue'),
(507212, 'HP:0100790', 'Hernia', 'MP:0005457', 'abnormal percent body fat/body weight', 0.47619047619047616, 7.212684573300959, 1.8532705419263225, 'UPHENO:0002712', 'abnormal connective tissue'),
(507213, 'HP:0100790', 'Hernia', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507214, 'HP:0100790', 'Hernia', 'MP:0003936', 'abnormal reproductive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507215, 'HP:0100790', 'Hernia', 'MP:0013941', 'abnormal enthesis morphology', 0.43478260869565216, 7.212684573300959, 1.7708613199453755, 'UPHENO:0002712', 'abnormal connective tissue'),
(507216, 'HP:0100790', 'Hernia', 'MP:0013558', 'abnormal exocrine gland morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507217, 'HP:0100790', 'Hernia', 'MP:0003115', 'abnormal respiratory system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507218, 'HP:0100790', 'Hernia', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507219, 'HP:0100790', 'Hernia', 'MP:0003942', 'abnormal urinary system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507220, 'HP:0100790', 'Hernia', 'MP:0010352', 'gastrointestinal tract polyps', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507221, 'HP:0100790', 'Hernia', 'MP:0001929', 'abnormal gametogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507222, 'HP:0100790', 'Hernia', 'MP:0005666', 'abnormal adipose tissue physiology', 0.45454545454545453, 7.212684573300959, 1.8106609257020134, 'UPHENO:0002712', 'abnormal connective tissue'),
(507223, 'HP:0100790', 'Hernia', 'MP:0003279', 'aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507224, 'HP:0100790', 'Hernia', 'MP:0020130', 'abnormal total fat pad weight', 0.43478260869565216, 7.212684573300959, 1.7708613199453755, 'UPHENO:0002712', 'abnormal connective tissue'),
(507225, 'HP:0100790', 'Hernia', 'MP:0013122', 'tail swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507226, 'HP:0100790', 'Hernia', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507227, 'HP:0100790', 'Hernia', 'MP:0020981', 'abnormal immune system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507228, 'HP:0100790', 'Hernia', 'MP:0003795', 'abnormal bone structure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507229, 'HP:0100790', 'Hernia', 'MP:0008923', 'thoracoschisis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507230, 'HP:0100790', 'Hernia', 'MP:0014062', 'nervous system inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507231, 'HP:0100790', 'Hernia', 'MP:0013800', 'abnormal pericardial fat pad morphology', 0.43478260869565216, 7.212684573300959, 1.7708613199453755, 'UPHENO:0002712', 'abnormal connective tissue'),
(507232, 'HP:0100790', 'Hernia', 'MP:0010678', 'abnormal skin adnexa morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507233, 'HP:0100790', 'Hernia', 'MP:0030222', 'hyperostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507234, 'HP:0100790', 'Hernia', 'MP:0003385', 'abnormal body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507235, 'HP:0100790', 'Hernia', 'MP:0000163', 'abnormal cartilage morphology', 0.43478260869565216, 7.212684573300959, 1.7708613199453755, 'UPHENO:0002712', 'abnormal connective tissue'),
(507236, 'HP:0100790', 'Hernia', 'MP:0031099', 'abnormal sputum morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507237, 'HP:0100790', 'Hernia', 'MP:0003797', 'abnormal compact bone morphology', 0.4166666666666667, 7.212684573300959, 1.7335758532222925, 'UPHENO:0002712', 'abnormal connective tissue'),
(507238, 'HP:0100790', 'Hernia', 'MP:0005360', 'urolithiasis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507239, 'HP:0100790', 'Hernia', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507240, 'HP:0100790', 'Hernia', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507241, 'HP:0100790', 'Hernia', 'MP:0002210', 'abnormal sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507242, 'HP:0100790', 'Hernia', 'MP:0020521', 'browned white adipose tissue morphology', 0.43478260869565216, 7.212684573300959, 1.7708613199453755, 'UPHENO:0002712', 'abnormal connective tissue'),
(507243, 'HP:0100790', 'Hernia', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507244, 'HP:0100790', 'Hernia', 'MP:0002160', 'abnormal reproductive system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507245, 'HP:0100790', 'Hernia', 'MP:0005334', 'abnormal fat pad morphology', 0.45454545454545453, 7.212684573300959, 1.8106609257020134, 'UPHENO:0002712', 'abnormal connective tissue'),
(507246, 'HP:0100790', 'Hernia', 'MP:0003119', 'abnormal digestive system development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507247, 'HP:0100790', 'Hernia', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507248, 'HP:0100790', 'Hernia', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507249, 'HP:0100790', 'Hernia', 'MP:0005500', 'abnormal gustatory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507250, 'HP:0100790', 'Hernia', 'MP:0006279', 'abnormal limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507251, 'HP:0100790', 'Hernia', 'MP:0002109', 'abnormal limb morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507252, 'HP:0100790', 'Hernia', 'MP:0013801', 'abnormal subscapular fat pad morphology', 0.43478260869565216, 7.212684573300959, 1.7708613199453755, 'UPHENO:0002712', 'abnormal connective tissue'),
(507253, 'HP:0100790', 'Hernia', 'MP:0000685', 'abnormal immune system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507254, 'HP:0100790', 'Hernia', 'MP:0031277', 'pectus carinatum', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507255, 'HP:0100790', 'Hernia', 'MP:0013120', 'urogenital swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507256, 'HP:0100790', 'Hernia', 'MP:0002971', 'abnormal brown adipose tissue morphology', 0.45454545454545453, 7.212684573300959, 1.8106609257020134, 'UPHENO:0002712', 'abnormal connective tissue'),
(507257, 'HP:0100790', 'Hernia', 'MP:0013177', 'abnormal tail tip morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507258, 'HP:0100790', 'Hernia', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507259, 'HP:0100790', 'Hernia', 'MP:0013125', 'thorax swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507260, 'HP:0100790', 'Hernia', 'MP:0002164', 'abnormal gland physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507261, 'HP:0100790', 'Hernia', 'MP:0013123', 'head/neck swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507262, 'HP:0100790', 'Hernia', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507263, 'HP:0100790', 'Hernia', 'MP:0003935', 'abnormal craniofacial development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507264, 'HP:0100790', 'Hernia', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507265, 'HP:0100790', 'Hernia', 'MP:0011167', 'abnormal adipose tissue development', 0.47619047619047616, 7.212684573300959, 1.8532705419263225, 'UPHENO:0002712', 'abnormal connective tissue'),
(507266, 'HP:0100790', 'Hernia', 'MP:0002163', 'abnormal gland morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507267, 'HP:0100790', 'Hernia', 'MP:0013283', 'failure of ventral body wall closure', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507268, 'HP:0100790', 'Hernia', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507269, 'HP:0100790', 'Hernia', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507270, 'HP:0100790', 'Hernia', 'MP:0002108', 'abnormal muscle morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507271, 'HP:0100790', 'Hernia', 'MP:0011174', 'lipodystrophy', 0.47619047619047616, 7.212684573300959, 1.8532705419263225, 'UPHENO:0002712', 'abnormal connective tissue'),
(507272, 'HP:0100790', 'Hernia', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507273, 'HP:0100790', 'Hernia', 'MP:0013126', 'teat swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507274, 'HP:0100790', 'Hernia', 'MP:0002836', 'abnormal chorion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507275, 'HP:0100790', 'Hernia', 'MP:0001985', 'abnormal gustatory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507276, 'HP:0100790', 'Hernia', 'MP:0000003', 'abnormal adipose tissue morphology', 0.5, 7.212684573300959, 1.899037199912229, 'UPHENO:0002712', 'abnormal connective tissue'),
(507277, 'HP:0100790', 'Hernia', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4166666666666667, 7.212684573300959, 1.7335758532222925, 'UPHENO:0002712', 'abnormal connective tissue'),
(507278, 'HP:0100790', 'Hernia', 'MP:0005458', 'increased percent body fat/body weight', 0.45454545454545453, 7.212684573300959, 1.8106609257020134, 'UPHENO:0002712', 'abnormal connective tissue'),
(507279, 'HP:0100790', 'Hernia', 'MP:0000733', 'abnormal muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507280, 'HP:0100790', 'Hernia', 'MP:0031310', 'abnormal cyst', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507281, 'HP:0100790', 'Hernia', 'MP:0013113', 'greasy tail', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507282, 'HP:0100790', 'Hernia', 'MP:0010478', 'intracranial aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507283, 'HP:0100790', 'Hernia', 'MP:0002132', 'abnormal respiratory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507284, 'HP:0100790', 'Hernia', 'MP:0005029', 'abnormal amnion morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(507285, 'HP:0011811', 'Impaired touch localization', 'MP:0006054', 'spinal hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507286, 'HP:0011811', 'Impaired touch localization', 'MP:0003996', 'clonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507287, 'HP:0011811', 'Impaired touch localization', 'MP:0012554', 'increased serum complement activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507288, 'HP:0011811', 'Impaired touch localization', 'MP:0014178', 'increased brain apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507289, 'HP:0011811', 'Impaired touch localization', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507290, 'HP:0011811', 'Impaired touch localization', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507291, 'HP:0011811', 'Impaired touch localization', 'MP:0008555', 'abnormal interferon secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507292, 'HP:0011811', 'Impaired touch localization', 'MP:0003091', 'abnormal cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507293, 'HP:0011811', 'Impaired touch localization', 'MP:0013182', 'increased spinal cord apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507294, 'HP:0011811', 'Impaired touch localization', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507295, 'HP:0011811', 'Impaired touch localization', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507296, 'HP:0011811', 'Impaired touch localization', 'MP:0003547', 'abnormal pulmonary pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507297, 'HP:0011811', 'Impaired touch localization', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507298, 'HP:0011811', 'Impaired touch localization', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507299, 'HP:0011811', 'Impaired touch localization', 'MP:0001916', 'intracerebral hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507300, 'HP:0011811', 'Impaired touch localization', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507301, 'HP:0011811', 'Impaired touch localization', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507302, 'HP:0011811', 'Impaired touch localization', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507303, 'HP:0011811', 'Impaired touch localization', 'MP:0005445', 'abnormal neurotransmitter secretion', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507304, 'HP:0011811', 'Impaired touch localization', 'MP:0008840', 'abnormal spike wave discharge', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507305, 'HP:0011811', 'Impaired touch localization', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507306, 'HP:0011811', 'Impaired touch localization', 'MP:0001473', 'reduced long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507307, 'HP:0011811', 'Impaired touch localization', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507308, 'HP:0011811', 'Impaired touch localization', 'MP:0003997', 'tonic-clonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507309, 'HP:0011811', 'Impaired touch localization', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507310, 'HP:0011811', 'Impaired touch localization', 'MP:0003217', 'increased spike-wave discharge type I', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507311, 'HP:0011811', 'Impaired touch localization', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507312, 'HP:0011811', 'Impaired touch localization', 'MP:0011928', 'abnormal mitral valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507313, 'HP:0011811', 'Impaired touch localization', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507314, 'HP:0011811', 'Impaired touch localization', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507315, 'HP:0011811', 'Impaired touch localization', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507316, 'HP:0011811', 'Impaired touch localization', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507317, 'HP:0011811', 'Impaired touch localization', 'MP:0031109', 'subarachnoid hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507318, 'HP:0011811', 'Impaired touch localization', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507319, 'HP:0011811', 'Impaired touch localization', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507320, 'HP:0011811', 'Impaired touch localization', 'MP:0010634', 'increased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507321, 'HP:0011811', 'Impaired touch localization', 'MP:0006053', 'hypothalamus hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507322, 'HP:0011811', 'Impaired touch localization', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507323, 'HP:0011811', 'Impaired touch localization', 'MP:0006114', 'cardiac murmur', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507324, 'HP:0011811', 'Impaired touch localization', 'MP:0003076', 'increased susceptibility to ischemic brain injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507325, 'HP:0011811', 'Impaired touch localization', 'MP:0004835', 'abnormal miniature endplate potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507326, 'HP:0011811', 'Impaired touch localization', 'MP:0001876', 'decreased inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507327, 'HP:0011811', 'Impaired touch localization', 'MP:0005333', 'decreased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507328, 'HP:0011811', 'Impaired touch localization', 'MP:0002906', 'increased susceptibility to pharmacologically induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507329, 'HP:0011811', 'Impaired touch localization', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507330, 'HP:0011811', 'Impaired touch localization', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507331, 'HP:0011811', 'Impaired touch localization', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507332, 'HP:0011811', 'Impaired touch localization', 'MP:0003472', 'increased summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507333, 'HP:0011811', 'Impaired touch localization', 'MP:0031117', 'subdural hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507334, 'HP:0011811', 'Impaired touch localization', 'MP:0010149', 'abnormal synaptic dopamine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507335, 'HP:0011811', 'Impaired touch localization', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507336, 'HP:0011811', 'Impaired touch localization', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507337, 'HP:0011811', 'Impaired touch localization', 'MP:0008814', 'decreased nerve conduction velocity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507338, 'HP:0011811', 'Impaired touch localization', 'MP:0013806', 'encephalopathy', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507339, 'HP:0011811', 'Impaired touch localization', 'MP:0002723', 'abnormal immune serum protein physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507340, 'HP:0011811', 'Impaired touch localization', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507341, 'HP:0011811', 'Impaired touch localization', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507342, 'HP:0011811', 'Impaired touch localization', 'MP:0009142', 'decreased prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507343, 'HP:0011811', 'Impaired touch localization', 'MP:0005645', 'abnormal hypothalamus physiology', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507344, 'HP:0011811', 'Impaired touch localization', 'MP:0008558', 'abnormal interferon-beta secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507345, 'HP:0011811', 'Impaired touch localization', 'MP:0001496', 'audiogenic seizures', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507346, 'HP:0011811', 'Impaired touch localization', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507347, 'HP:0011811', 'Impaired touch localization', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507348, 'HP:0011811', 'Impaired touch localization', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507349, 'HP:0011811', 'Impaired touch localization', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507350, 'HP:0011811', 'Impaired touch localization', 'MP:0004415', 'abnormal cochlear nerve compound action potential', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507351, 'HP:0011811', 'Impaired touch localization', 'MP:0003901', 'abnormal PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507352, 'HP:0011811', 'Impaired touch localization', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507353, 'HP:0011811', 'Impaired touch localization', 'MP:0012011', 'febrile seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507354, 'HP:0011811', 'Impaired touch localization', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507355, 'HP:0011811', 'Impaired touch localization', 'MP:0003463', 'abnormal single cell response', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507356, 'HP:0011811', 'Impaired touch localization', 'MP:0003990', 'decreased neurotransmitter release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507357, 'HP:0011811', 'Impaired touch localization', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507358, 'HP:0011811', 'Impaired touch localization', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507359, 'HP:0011811', 'Impaired touch localization', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507360, 'HP:0011811', 'Impaired touch localization', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507361, 'HP:0011811', 'Impaired touch localization', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507362, 'HP:0011811', 'Impaired touch localization', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507363, 'HP:0011811', 'Impaired touch localization', 'MP:0013438', 'dysmyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507364, 'HP:0011811', 'Impaired touch localization', 'MP:0031334', 'increased inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507365, 'HP:0011811', 'Impaired touch localization', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507366, 'HP:0011811', 'Impaired touch localization', 'MP:0006138', 'congestive heart failure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507367, 'HP:0011811', 'Impaired touch localization', 'MP:0020000', 'abnormal response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507368, 'HP:0011811', 'Impaired touch localization', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507369, 'HP:0011811', 'Impaired touch localization', 'MP:0001846', 'increased inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507370, 'HP:0011811', 'Impaired touch localization', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507371, 'HP:0011811', 'Impaired touch localization', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507372, 'HP:0011811', 'Impaired touch localization', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507373, 'HP:0011811', 'Impaired touch localization', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507374, 'HP:0011811', 'Impaired touch localization', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507375, 'HP:0011811', 'Impaired touch localization', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507376, 'HP:0011811', 'Impaired touch localization', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507377, 'HP:0011811', 'Impaired touch localization', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507378, 'HP:0011811', 'Impaired touch localization', 'MP:0003216', 'absence seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507379, 'HP:0011811', 'Impaired touch localization', 'MP:0014252', 'abnormal paired-pulse ratio', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507380, 'HP:0011811', 'Impaired touch localization', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507381, 'HP:0011811', 'Impaired touch localization', 'MP:0001475', 'reduced long-term depression', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507382, 'HP:0011811', 'Impaired touch localization', 'MP:0003726', 'decreased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507383, 'HP:0011811', 'Impaired touch localization', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507384, 'HP:0011811', 'Impaired touch localization', 'MP:0000947', 'convulsive seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507385, 'HP:0011811', 'Impaired touch localization', 'MP:0003219', 'increased spike-wave discharge type II', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507386, 'HP:0011811', 'Impaired touch localization', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507387, 'HP:0011811', 'Impaired touch localization', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507388, 'HP:0011811', 'Impaired touch localization', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507389, 'HP:0011811', 'Impaired touch localization', 'MP:0014253', 'decreased paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507390, 'HP:0011811', 'Impaired touch localization', 'MP:0003412', 'abnormal afterhyperpolarization', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507391, 'HP:0011811', 'Impaired touch localization', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507392, 'HP:0011811', 'Impaired touch localization', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507393, 'HP:0011811', 'Impaired touch localization', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507394, 'HP:0011811', 'Impaired touch localization', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507395, 'HP:0011811', 'Impaired touch localization', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507396, 'HP:0011811', 'Impaired touch localization', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507397, 'HP:0011811', 'Impaired touch localization', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507398, 'HP:0011811', 'Impaired touch localization', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507399, 'HP:0011811', 'Impaired touch localization', 'MP:0000951', 'sporadic seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507400, 'HP:0011811', 'Impaired touch localization', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507401, 'HP:0011811', 'Impaired touch localization', 'MP:0008921', 'increased neurotransmitter release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507402, 'HP:0011811', 'Impaired touch localization', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507403, 'HP:0011811', 'Impaired touch localization', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507404, 'HP:0011811', 'Impaired touch localization', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507405, 'HP:0011811', 'Impaired touch localization', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507406, 'HP:0011811', 'Impaired touch localization', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507407, 'HP:0011811', 'Impaired touch localization', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507408, 'HP:0011811', 'Impaired touch localization', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507409, 'HP:0011811', 'Impaired touch localization', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507410, 'HP:0011811', 'Impaired touch localization', 'MP:0011938', 'prolonged PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507411, 'HP:0011811', 'Impaired touch localization', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507412, 'HP:0011811', 'Impaired touch localization', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507413, 'HP:0011811', 'Impaired touch localization', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507414, 'HP:0011811', 'Impaired touch localization', 'MP:0030990', 'nerve inflammation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507415, 'HP:0011811', 'Impaired touch localization', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507416, 'HP:0011811', 'Impaired touch localization', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507417, 'HP:0011811', 'Impaired touch localization', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507418, 'HP:0011811', 'Impaired touch localization', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507419, 'HP:0011811', 'Impaired touch localization', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507420, 'HP:0011811', 'Impaired touch localization', 'MP:0020002', 'increased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507421, 'HP:0011811', 'Impaired touch localization', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507422, 'HP:0011811', 'Impaired touch localization', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507423, 'HP:0011811', 'Impaired touch localization', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507424, 'HP:0011811', 'Impaired touch localization', 'MP:0001902', 'reduced NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507425, 'HP:0011811', 'Impaired touch localization', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507426, 'HP:0011811', 'Impaired touch localization', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507427, 'HP:0011811', 'Impaired touch localization', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507428, 'HP:0011811', 'Impaired touch localization', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507429, 'HP:0011811', 'Impaired touch localization', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507430, 'HP:0011811', 'Impaired touch localization', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507431, 'HP:0011811', 'Impaired touch localization', 'MP:0001634', 'internal hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507432, 'HP:0011811', 'Impaired touch localization', 'MP:0004811', 'abnormal neuron physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507433, 'HP:0011811', 'Impaired touch localization', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507434, 'HP:0011811', 'Impaired touch localization', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507435, 'HP:0011811', 'Impaired touch localization', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507436, 'HP:0011811', 'Impaired touch localization', 'MP:0001917', 'intraventricular hemorrhage', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507437, 'HP:0011811', 'Impaired touch localization', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507438, 'HP:0011811', 'Impaired touch localization', 'MP:0001909', 'reduced NMDA receptor mediated synaptic activity in barrel cortex', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507439, 'HP:0011811', 'Impaired touch localization', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507440, 'HP:0011811', 'Impaired touch localization', 'MP:0001934', 'increased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507441, 'HP:0011811', 'Impaired touch localization', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507442, 'HP:0011811', 'Impaired touch localization', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507443, 'HP:0011811', 'Impaired touch localization', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507444, 'HP:0011811', 'Impaired touch localization', 'MP:0011927', 'abnormal cardiac valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507445, 'HP:0011811', 'Impaired touch localization', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507446, 'HP:0011811', 'Impaired touch localization', 'MP:0002409', 'decreased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507447, 'HP:0011811', 'Impaired touch localization', 'MP:0001915', 'intracranial hemorrhage', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507448, 'HP:0011811', 'Impaired touch localization', 'MP:0004994', 'abnormal brain wave pattern', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507449, 'HP:0011811', 'Impaired touch localization', 'MP:0003690', 'abnormal glial cell physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507450, 'HP:0011811', 'Impaired touch localization', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507451, 'HP:0011811', 'Impaired touch localization', 'MP:0031110', 'meningitis', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507452, 'HP:0011811', 'Impaired touch localization', 'MP:0003464', 'abnormal single cell response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507453, 'HP:0011811', 'Impaired touch localization', 'MP:0004770', 'abnormal synaptic vesicle recycling', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507454, 'HP:0011811', 'Impaired touch localization', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507455, 'HP:0011811', 'Impaired touch localization', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507456, 'HP:0011811', 'Impaired touch localization', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507457, 'HP:0011811', 'Impaired touch localization', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507458, 'HP:0011811', 'Impaired touch localization', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507459, 'HP:0011811', 'Impaired touch localization', 'MP:0001650', 'abnormal seizure response to electrical stimulation', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507460, 'HP:0011811', 'Impaired touch localization', 'MP:0030132', 'periodontium inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507461, 'HP:0011811', 'Impaired touch localization', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507462, 'HP:0011811', 'Impaired touch localization', 'MP:0009141', 'increased prepulse inhibition', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507463, 'HP:0011811', 'Impaired touch localization', 'MP:0005446', 'abnormal synaptic epinephrine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507464, 'HP:0011811', 'Impaired touch localization', 'MP:0002918', 'abnormal paired-pulse facilitation', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507465, 'HP:0011811', 'Impaired touch localization', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507466, 'HP:0011811', 'Impaired touch localization', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507467, 'HP:0011811', 'Impaired touch localization', 'MP:0013642', 'decreased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507468, 'HP:0011811', 'Impaired touch localization', 'MP:0012502', 'decreased hindbrain apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507469, 'HP:0011811', 'Impaired touch localization', 'MP:0021026', 'decreased cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507470, 'HP:0011811', 'Impaired touch localization', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507471, 'HP:0011811', 'Impaired touch localization', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507472, 'HP:0011811', 'Impaired touch localization', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507473, 'HP:0011811', 'Impaired touch localization', 'MP:0002420', 'abnormal adaptive immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507474, 'HP:0011811', 'Impaired touch localization', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507475, 'HP:0011811', 'Impaired touch localization', 'MP:0020154', 'impaired humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507476, 'HP:0011811', 'Impaired touch localization', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507477, 'HP:0011811', 'Impaired touch localization', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507478, 'HP:0011811', 'Impaired touch localization', 'MP:0004879', 'decreased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507479, 'HP:0011811', 'Impaired touch localization', 'MP:0000343', 'abnormal response to cardiac infarction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507480, 'HP:0011811', 'Impaired touch localization', 'MP:0002919', 'enhanced paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507481, 'HP:0011811', 'Impaired touch localization', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507482, 'HP:0011811', 'Impaired touch localization', 'MP:0003633', 'abnormal nervous system physiology', 0.6086956521739131, 7.291997705654976, 2.1068002513514026, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507483, 'HP:0011811', 'Impaired touch localization', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507484, 'HP:0011811', 'Impaired touch localization', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507485, 'HP:0011811', 'Impaired touch localization', 'MP:0004751', 'increased length of allograft survival', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507486, 'HP:0011811', 'Impaired touch localization', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507487, 'HP:0011811', 'Impaired touch localization', 'MP:0003298', 'choking', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507488, 'HP:0011811', 'Impaired touch localization', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507489, 'HP:0011811', 'Impaired touch localization', 'MP:0002498', 'abnormal acute inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507490, 'HP:0011811', 'Impaired touch localization', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507491, 'HP:0011811', 'Impaired touch localization', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507492, 'HP:0011811', 'Impaired touch localization', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507493, 'HP:0011811', 'Impaired touch localization', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507494, 'HP:0011811', 'Impaired touch localization', 'MP:0014256', 'decreased paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507495, 'HP:0011811', 'Impaired touch localization', 'MP:0011273', 'prolonged excitatory postsynaptic current decay time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507496, 'HP:0011811', 'Impaired touch localization', 'MP:0006088', 'abnormal blood-cerebrospinal fluid barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507497, 'HP:0011811', 'Impaired touch localization', 'MP:0020846', 'abnormal cell motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507498, 'HP:0011811', 'Impaired touch localization', 'MP:0011271', 'prolonged excitatory postsynaptic current rise time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507499, 'HP:0011811', 'Impaired touch localization', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507500, 'HP:0011811', 'Impaired touch localization', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507501, 'HP:0011811', 'Impaired touch localization', 'MP:0010368', 'abnormal lymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507502, 'HP:0011811', 'Impaired touch localization', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507503, 'HP:0011811', 'Impaired touch localization', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507504, 'HP:0011811', 'Impaired touch localization', 'MP:0011952', 'decreased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507505, 'HP:0011811', 'Impaired touch localization', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507506, 'HP:0011811', 'Impaired touch localization', 'MP:0001752', 'abnormal hypothalamus secretion', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507507, 'HP:0011811', 'Impaired touch localization', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507508, 'HP:0011811', 'Impaired touch localization', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507509, 'HP:0011811', 'Impaired touch localization', 'MP:0011399', 'increased endoneurial fluid pressure', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507510, 'HP:0011811', 'Impaired touch localization', 'MP:0003929', 'decreased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507511, 'HP:0011811', 'Impaired touch localization', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507512, 'HP:0011811', 'Impaired touch localization', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507513, 'HP:0011811', 'Impaired touch localization', 'MP:0010050', 'hypermyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507514, 'HP:0011811', 'Impaired touch localization', 'MP:0014254', 'increased paired-pulse ratio', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507515, 'HP:0011811', 'Impaired touch localization', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507516, 'HP:0011811', 'Impaired touch localization', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507517, 'HP:0011811', 'Impaired touch localization', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507518, 'HP:0011811', 'Impaired touch localization', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507519, 'HP:0011811', 'Impaired touch localization', 'MP:0005167', 'abnormal blood-brain barrier function', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507520, 'HP:0011811', 'Impaired touch localization', 'MP:0001500', 'decreased kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507521, 'HP:0011811', 'Impaired touch localization', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507522, 'HP:0011811', 'Impaired touch localization', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507523, 'HP:0011811', 'Impaired touch localization', 'MP:0002421', 'abnormal cell-mediated immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507524, 'HP:0011811', 'Impaired touch localization', 'MP:0003635', 'abnormal synaptic transmission', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507525, 'HP:0011811', 'Impaired touch localization', 'MP:0003202', 'abnormal neuron apoptosis', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507526, 'HP:0011811', 'Impaired touch localization', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507527, 'HP:0011811', 'Impaired touch localization', 'MP:0003482', 'increased nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507528, 'HP:0011811', 'Impaired touch localization', 'MP:0001912', 'increased cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507529, 'HP:0011811', 'Impaired touch localization', 'MP:0002915', 'abnormal synaptic depression', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507530, 'HP:0011811', 'Impaired touch localization', 'MP:0005005', 'abnormal self tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507531, 'HP:0011811', 'Impaired touch localization', 'MP:0003218', 'decreased spike-wave discharge type I', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507532, 'HP:0011811', 'Impaired touch localization', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507533, 'HP:0011811', 'Impaired touch localization', 'MP:0001499', 'abnormal kindling response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507534, 'HP:0011811', 'Impaired touch localization', 'MP:0014179', 'abnormal blood-retina barrier function', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507535, 'HP:0011811', 'Impaired touch localization', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507536, 'HP:0011811', 'Impaired touch localization', 'MP:0003009', 'abnormal cytokine secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507537, 'HP:0011811', 'Impaired touch localization', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507538, 'HP:0011811', 'Impaired touch localization', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507539, 'HP:0011811', 'Impaired touch localization', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507540, 'HP:0011811', 'Impaired touch localization', 'MP:0012565', 'perivasculitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507541, 'HP:0011811', 'Impaired touch localization', 'MP:0031129', 'left-to-right shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507542, 'HP:0011811', 'Impaired touch localization', 'MP:0003468', 'increased single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507543, 'HP:0011811', 'Impaired touch localization', 'MP:0011045', 'decreased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507544, 'HP:0011811', 'Impaired touch localization', 'MP:0013145', 'eye discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507545, 'HP:0011811', 'Impaired touch localization', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507546, 'HP:0011811', 'Impaired touch localization', 'MP:0010514', 'fragmented QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507547, 'HP:0011811', 'Impaired touch localization', 'MP:0001900', 'impaired synaptic plasticity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507548, 'HP:0011811', 'Impaired touch localization', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507549, 'HP:0011811', 'Impaired touch localization', 'MP:0002578', 'impaired ability to fire action potentials', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507550, 'HP:0011811', 'Impaired touch localization', 'MP:0004085', 'abnormal heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507551, 'HP:0011811', 'Impaired touch localization', 'MP:0004145', 'abnormal muscle electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507552, 'HP:0011811', 'Impaired touch localization', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507553, 'HP:0011811', 'Impaired touch localization', 'MP:0021009', 'abnormal synaptic physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507554, 'HP:0011811', 'Impaired touch localization', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507555, 'HP:0011811', 'Impaired touch localization', 'MP:0012745', 'abnormal neural crest cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507556, 'HP:0011811', 'Impaired touch localization', 'MP:0008748', 'abnormal central T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507557, 'HP:0011811', 'Impaired touch localization', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507558, 'HP:0011811', 'Impaired touch localization', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507559, 'HP:0011811', 'Impaired touch localization', 'MP:0010559', 'heart block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507560, 'HP:0011811', 'Impaired touch localization', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507561, 'HP:0011811', 'Impaired touch localization', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507562, 'HP:0011811', 'Impaired touch localization', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507563, 'HP:0011811', 'Impaired touch localization', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507564, 'HP:0011811', 'Impaired touch localization', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507565, 'HP:0011811', 'Impaired touch localization', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507566, 'HP:0011811', 'Impaired touch localization', 'MP:0000920', 'abnormal myelination', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507567, 'HP:0011811', 'Impaired touch localization', 'MP:0003444', 'abnormal neurotransmitter uptake', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507568, 'HP:0011811', 'Impaired touch localization', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507569, 'HP:0011811', 'Impaired touch localization', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507570, 'HP:0011811', 'Impaired touch localization', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507571, 'HP:0011811', 'Impaired touch localization', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507572, 'HP:0011811', 'Impaired touch localization', 'MP:0001756', 'abnormal urination', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507573, 'HP:0011811', 'Impaired touch localization', 'MP:0002634', 'abnormal sensorimotor gating', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507574, 'HP:0011811', 'Impaired touch localization', 'MP:0011954', 'shortened PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507575, 'HP:0011811', 'Impaired touch localization', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507576, 'HP:0011811', 'Impaired touch localization', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507577, 'HP:0011811', 'Impaired touch localization', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507578, 'HP:0011811', 'Impaired touch localization', 'MP:0006052', 'cerebellum hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507579, 'HP:0011811', 'Impaired touch localization', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507580, 'HP:0011811', 'Impaired touch localization', 'MP:0000327', 'hemosiderinuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507581, 'HP:0011811', 'Impaired touch localization', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507582, 'HP:0011811', 'Impaired touch localization', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507583, 'HP:0011811', 'Impaired touch localization', 'MP:0009475', 'abnormal nicotine-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507584, 'HP:0011811', 'Impaired touch localization', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507585, 'HP:0011811', 'Impaired touch localization', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507586, 'HP:0011811', 'Impaired touch localization', 'MP:0008775', 'abnormal heart ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507587, 'HP:0011811', 'Impaired touch localization', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507588, 'HP:0011811', 'Impaired touch localization', 'MP:0011001', 'absence of AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507589, 'HP:0011811', 'Impaired touch localization', 'MP:0003477', 'abnormal nerve fiber response', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507590, 'HP:0011811', 'Impaired touch localization', 'MP:0031088', 'coughing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507591, 'HP:0011811', 'Impaired touch localization', 'MP:0003467', 'abnormal single cell response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507592, 'HP:0011811', 'Impaired touch localization', 'MP:0006058', 'decreased cerebral infarct size', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507593, 'HP:0011811', 'Impaired touch localization', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507594, 'HP:0011811', 'Impaired touch localization', 'MP:0004037', 'increased muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507595, 'HP:0011811', 'Impaired touch localization', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507596, 'HP:0011811', 'Impaired touch localization', 'MP:0002912', 'abnormal excitatory postsynaptic potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507597, 'HP:0011811', 'Impaired touch localization', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507598, 'HP:0011811', 'Impaired touch localization', 'MP:0010513', 'abnormal ventricular activation time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507599, 'HP:0011811', 'Impaired touch localization', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507600, 'HP:0011811', 'Impaired touch localization', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507601, 'HP:0011811', 'Impaired touch localization', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507602, 'HP:0011811', 'Impaired touch localization', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507603, 'HP:0011811', 'Impaired touch localization', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507604, 'HP:0011811', 'Impaired touch localization', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507605, 'HP:0011811', 'Impaired touch localization', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507606, 'HP:0011811', 'Impaired touch localization', 'MP:0011269', 'increased excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507607, 'HP:0011811', 'Impaired touch localization', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507608, 'HP:0011811', 'Impaired touch localization', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507609, 'HP:0011811', 'Impaired touch localization', 'MP:0008008', 'early cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507610, 'HP:0011811', 'Impaired touch localization', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507611, 'HP:0011811', 'Impaired touch localization', 'MP:0001629', 'abnormal heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507612, 'HP:0011811', 'Impaired touch localization', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507613, 'HP:0011811', 'Impaired touch localization', 'MP:0001835', 'abnormal antigen presentation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507614, 'HP:0011811', 'Impaired touch localization', 'MP:0001899', 'absent long-term depression', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507615, 'HP:0011811', 'Impaired touch localization', 'MP:0011267', 'abnormal excitatory postsynaptic current amplitude', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507616, 'HP:0011811', 'Impaired touch localization', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507617, 'HP:0011811', 'Impaired touch localization', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507618, 'HP:0011811', 'Impaired touch localization', 'MP:0005000', 'abnormal immune tolerance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507619, 'HP:0011811', 'Impaired touch localization', 'MP:0003480', 'increased nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507620, 'HP:0011811', 'Impaired touch localization', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507621, 'HP:0011811', 'Impaired touch localization', 'MP:0030129', 'tongue inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507622, 'HP:0011811', 'Impaired touch localization', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507623, 'HP:0011811', 'Impaired touch localization', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507624, 'HP:0011811', 'Impaired touch localization', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507625, 'HP:0011811', 'Impaired touch localization', 'MP:0003393', 'decreased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507626, 'HP:0011811', 'Impaired touch localization', 'MP:0012553', 'decreased serum complement activity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507627, 'HP:0011811', 'Impaired touch localization', 'MP:0011920', 'abnormal S wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507628, 'HP:0011811', 'Impaired touch localization', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507629, 'HP:0011811', 'Impaired touch localization', 'MP:0001533', 'abnormal skeleton physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507630, 'HP:0011811', 'Impaired touch localization', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507631, 'HP:0011811', 'Impaired touch localization', 'MP:0003481', 'decreased nerve fiber response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507632, 'HP:0011811', 'Impaired touch localization', 'MP:0030987', 'spinal cord inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507633, 'HP:0011811', 'Impaired touch localization', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507634, 'HP:0011811', 'Impaired touch localization', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507635, 'HP:0011811', 'Impaired touch localization', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507636, 'HP:0011811', 'Impaired touch localization', 'MP:0002419', 'abnormal innate immunity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507637, 'HP:0011811', 'Impaired touch localization', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507638, 'HP:0011811', 'Impaired touch localization', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507639, 'HP:0011811', 'Impaired touch localization', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507640, 'HP:0011811', 'Impaired touch localization', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507641, 'HP:0011811', 'Impaired touch localization', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507642, 'HP:0011811', 'Impaired touch localization', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507643, 'HP:0011811', 'Impaired touch localization', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507644, 'HP:0011811', 'Impaired touch localization', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507645, 'HP:0011811', 'Impaired touch localization', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507646, 'HP:0011811', 'Impaired touch localization', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507647, 'HP:0011811', 'Impaired touch localization', 'MP:0031111', 'meningoencephalitis', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507648, 'HP:0011811', 'Impaired touch localization', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507649, 'HP:0011811', 'Impaired touch localization', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507650, 'HP:0011811', 'Impaired touch localization', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507651, 'HP:0011811', 'Impaired touch localization', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507652, 'HP:0011811', 'Impaired touch localization', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507653, 'HP:0011811', 'Impaired touch localization', 'MP:0004156', 'abnormal QT variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507654, 'HP:0011811', 'Impaired touch localization', 'MP:0009435', 'abnormal miniature inhibitory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507655, 'HP:0011811', 'Impaired touch localization', 'MP:0000423', 'delayed hair regrowth', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507656, 'HP:0011811', 'Impaired touch localization', 'MP:0002472', 'impaired complement alternative pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507657, 'HP:0011811', 'Impaired touch localization', 'MP:0005043', 'defective assembly of class II molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507658, 'HP:0011811', 'Impaired touch localization', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507659, 'HP:0011811', 'Impaired touch localization', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507660, 'HP:0011811', 'Impaired touch localization', 'MP:0002128', 'abnormal blood circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507661, 'HP:0011811', 'Impaired touch localization', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507662, 'HP:0011811', 'Impaired touch localization', 'MP:0005402', 'abnormal action potential', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507663, 'HP:0011811', 'Impaired touch localization', 'MP:0011002', 'enhanced AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507664, 'HP:0011811', 'Impaired touch localization', 'MP:0012006', 'abnormal hippocampus physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507665, 'HP:0011811', 'Impaired touch localization', 'MP:0006324', 'abnormal cochlear nerve fiber response', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507666, 'HP:0011811', 'Impaired touch localization', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507667, 'HP:0011811', 'Impaired touch localization', 'MP:0002406', 'increased susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507668, 'HP:0011811', 'Impaired touch localization', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507669, 'HP:0011811', 'Impaired touch localization', 'MP:0008744', 'abnormal B cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507670, 'HP:0011811', 'Impaired touch localization', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507671, 'HP:0011811', 'Impaired touch localization', 'MP:0003471', 'abnormal summary potential threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507672, 'HP:0011811', 'Impaired touch localization', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507673, 'HP:0011811', 'Impaired touch localization', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507674, 'HP:0011811', 'Impaired touch localization', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507675, 'HP:0011811', 'Impaired touch localization', 'MP:0002826', 'tonic seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507676, 'HP:0011811', 'Impaired touch localization', 'MP:0014255', 'increased paired-pulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507677, 'HP:0011811', 'Impaired touch localization', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507678, 'HP:0011811', 'Impaired touch localization', 'MP:0011987', 'abnormal GABAergic neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507679, 'HP:0011811', 'Impaired touch localization', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507680, 'HP:0011811', 'Impaired touch localization', 'MP:0021084', 'decreased cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507681, 'HP:0011811', 'Impaired touch localization', 'MP:0013570', 'abnormal neuroendocrine gland physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507682, 'HP:0011811', 'Impaired touch localization', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507683, 'HP:0011811', 'Impaired touch localization', 'MP:0010753', 'improved mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507684, 'HP:0011811', 'Impaired touch localization', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507685, 'HP:0011811', 'Impaired touch localization', 'MP:0010741', 'abnormal melanocyte proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507686, 'HP:0011811', 'Impaired touch localization', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507687, 'HP:0011811', 'Impaired touch localization', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507688, 'HP:0011811', 'Impaired touch localization', 'MP:0011951', 'increased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507689, 'HP:0011811', 'Impaired touch localization', 'MP:0012349', 'increased susceptibility to induction of seizure by inducing agent', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507690, 'HP:0011811', 'Impaired touch localization', 'MP:0002195', 'psychomotor seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507691, 'HP:0011811', 'Impaired touch localization', 'MP:0010519', 'atrioventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507692, 'HP:0011811', 'Impaired touch localization', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507693, 'HP:0011811', 'Impaired touch localization', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507694, 'HP:0011811', 'Impaired touch localization', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507695, 'HP:0011811', 'Impaired touch localization', 'MP:0011919', 'abnormal R wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507696, 'HP:0011811', 'Impaired touch localization', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507697, 'HP:0011811', 'Impaired touch localization', 'MP:0002206', 'abnormal CNS synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507698, 'HP:0011811', 'Impaired touch localization', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507699, 'HP:0011811', 'Impaired touch localization', 'MP:0002921', 'abnormal post-tetanic potentiation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507700, 'HP:0011811', 'Impaired touch localization', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507701, 'HP:0011811', 'Impaired touch localization', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507702, 'HP:0011811', 'Impaired touch localization', 'MP:0010028', 'aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507703, 'HP:0011811', 'Impaired touch localization', 'MP:0005646', 'abnormal pituitary gland physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507704, 'HP:0011811', 'Impaired touch localization', 'MP:0021027', 'abnormal cerebrospinal fluid amyloid beta 40 isoform level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507705, 'HP:0011811', 'Impaired touch localization', 'MP:0002207', 'abnormal long-term potentiation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507706, 'HP:0011811', 'Impaired touch localization', 'MP:0003470', 'abnormal summary potential', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507707, 'HP:0011811', 'Impaired touch localization', 'MP:0031128', 'cardiovascular shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507708, 'HP:0011811', 'Impaired touch localization', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507709, 'HP:0011811', 'Impaired touch localization', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507710, 'HP:0011811', 'Impaired touch localization', 'MP:0002911', 'abnormal inhibitory postsynaptic potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507711, 'HP:0011811', 'Impaired touch localization', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507712, 'HP:0011811', 'Impaired touch localization', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507713, 'HP:0011811', 'Impaired touch localization', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507714, 'HP:0011811', 'Impaired touch localization', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507715, 'HP:0011811', 'Impaired touch localization', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507716, 'HP:0011811', 'Impaired touch localization', 'MP:0003008', 'enhanced long-term potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507717, 'HP:0011811', 'Impaired touch localization', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507718, 'HP:0011811', 'Impaired touch localization', 'MP:0004807', 'abnormal paired-pulse inhibition', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507719, 'HP:0011811', 'Impaired touch localization', 'MP:0005025', 'abnormal response to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507720, 'HP:0011811', 'Impaired touch localization', 'MP:0001898', 'abnormal long-term depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507721, 'HP:0011811', 'Impaired touch localization', 'MP:0011274', 'short excitatory postsynaptic current decay time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507722, 'HP:0011811', 'Impaired touch localization', 'MP:0008942', 'abnormal induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507723, 'HP:0011811', 'Impaired touch localization', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507724, 'HP:0011811', 'Impaired touch localization', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507725, 'HP:0011811', 'Impaired touch localization', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507726, 'HP:0011811', 'Impaired touch localization', 'MP:0000921', 'demyelination', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507727, 'HP:0011811', 'Impaired touch localization', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507728, 'HP:0011811', 'Impaired touch localization', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507729, 'HP:0011811', 'Impaired touch localization', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507730, 'HP:0011811', 'Impaired touch localization', 'MP:0003898', 'abnormal QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507731, 'HP:0011811', 'Impaired touch localization', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507732, 'HP:0011811', 'Impaired touch localization', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507733, 'HP:0011811', 'Impaired touch localization', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507734, 'HP:0011811', 'Impaired touch localization', 'MP:0012382', 'abnormal blood cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507735, 'HP:0011811', 'Impaired touch localization', 'MP:0003741', 'tinnitus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507736, 'HP:0011811', 'Impaired touch localization', 'MP:0004211', 'abnormal sour taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507737, 'HP:0011811', 'Impaired touch localization', 'MP:0010505', 'abnormal T wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507738, 'HP:0011811', 'Impaired touch localization', 'MP:0000948', 'nonconvulsive seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507739, 'HP:0011811', 'Impaired touch localization', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507740, 'HP:0011811', 'Impaired touch localization', 'MP:0002327', 'abnormal respiratory function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507741, 'HP:0011811', 'Impaired touch localization', 'MP:0005044', 'sepsis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507742, 'HP:0011811', 'Impaired touch localization', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507743, 'HP:0011811', 'Impaired touch localization', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507744, 'HP:0011811', 'Impaired touch localization', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507745, 'HP:0011811', 'Impaired touch localization', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507746, 'HP:0011811', 'Impaired touch localization', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507747, 'HP:0011811', 'Impaired touch localization', 'MP:0001901', 'absence of NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507748, 'HP:0011811', 'Impaired touch localization', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507749, 'HP:0011811', 'Impaired touch localization', 'MP:0021083', 'increased cerebrospinal fluid amyloid beta 42 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507750, 'HP:0011811', 'Impaired touch localization', 'MP:0031471', 'abnormal micropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507751, 'HP:0011811', 'Impaired touch localization', 'MP:0003489', 'increased channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507752, 'HP:0011811', 'Impaired touch localization', 'MP:0031333', 'decreased inhibitory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507753, 'HP:0011811', 'Impaired touch localization', 'MP:0014046', 'abnormal mitophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507754, 'HP:0011811', 'Impaired touch localization', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507755, 'HP:0011811', 'Impaired touch localization', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507756, 'HP:0011811', 'Impaired touch localization', 'MP:0003484', 'abnormal channel response', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507757, 'HP:0011811', 'Impaired touch localization', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507758, 'HP:0011811', 'Impaired touch localization', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507759, 'HP:0011811', 'Impaired touch localization', 'MP:0004752', 'decreased length of allograft survival', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507760, 'HP:0011811', 'Impaired touch localization', 'MP:0008747', 'abnormal T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507761, 'HP:0011811', 'Impaired touch localization', 'MP:0005671', 'abnormal response to transplant', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507762, 'HP:0011811', 'Impaired touch localization', 'MP:0004836', 'abnormal synaptic acetylcholine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507763, 'HP:0011811', 'Impaired touch localization', 'MP:0003465', 'increased single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507764, 'HP:0011811', 'Impaired touch localization', 'MP:0012261', 'increased hindbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507765, 'HP:0011811', 'Impaired touch localization', 'MP:0011994', 'increased nerve conduction velocity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507766, 'HP:0011811', 'Impaired touch localization', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507767, 'HP:0011811', 'Impaired touch localization', 'MP:0021082', 'abnormal cerebrospinal fluid amyloid beta 42 isoform level', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507768, 'HP:0011811', 'Impaired touch localization', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507769, 'HP:0011811', 'Impaired touch localization', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507770, 'HP:0011811', 'Impaired touch localization', 'MP:0006051', 'brainstem hemorrhage', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507771, 'HP:0011811', 'Impaired touch localization', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507772, 'HP:0011811', 'Impaired touch localization', 'MP:0010560', 'intraventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507773, 'HP:0011811', 'Impaired touch localization', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507774, 'HP:0011811', 'Impaired touch localization', 'MP:0003234', 'enhanced NMDA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507775, 'HP:0011811', 'Impaired touch localization', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507776, 'HP:0011811', 'Impaired touch localization', 'MP:0013971', 'blood in lymph vessels', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507777, 'HP:0011811', 'Impaired touch localization', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507778, 'HP:0011811', 'Impaired touch localization', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507779, 'HP:0011811', 'Impaired touch localization', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507780, 'HP:0011811', 'Impaired touch localization', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507781, 'HP:0011811', 'Impaired touch localization', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507782, 'HP:0011811', 'Impaired touch localization', 'MP:0002922', 'decreased post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507783, 'HP:0011811', 'Impaired touch localization', 'MP:0002923', 'increased post-tetanic potentiation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507784, 'HP:0011811', 'Impaired touch localization', 'MP:0003777', 'lip inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507785, 'HP:0011811', 'Impaired touch localization', 'MP:0001790', 'abnormal immune system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507786, 'HP:0011811', 'Impaired touch localization', 'MP:0008003', 'achlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507787, 'HP:0011811', 'Impaired touch localization', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507788, 'HP:0011811', 'Impaired touch localization', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507789, 'HP:0011811', 'Impaired touch localization', 'MP:0003490', 'decreased channel response threshold', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507790, 'HP:0011811', 'Impaired touch localization', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507791, 'HP:0011811', 'Impaired touch localization', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507792, 'HP:0011811', 'Impaired touch localization', 'MP:0002193', 'minimal clonic seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507793, 'HP:0011811', 'Impaired touch localization', 'MP:0006277', 'abnormal parasympathetic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507794, 'HP:0011811', 'Impaired touch localization', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507795, 'HP:0011811', 'Impaired touch localization', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507796, 'HP:0011811', 'Impaired touch localization', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507797, 'HP:0011811', 'Impaired touch localization', 'MP:0004859', 'abnormal synaptic plasticity', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507798, 'HP:0011811', 'Impaired touch localization', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507799, 'HP:0011811', 'Impaired touch localization', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507800, 'HP:0011811', 'Impaired touch localization', 'MP:0004143', 'muscle hypertonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507801, 'HP:0011811', 'Impaired touch localization', 'MP:0003475', 'increased summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507802, 'HP:0011811', 'Impaired touch localization', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507803, 'HP:0011811', 'Impaired touch localization', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507804, 'HP:0011811', 'Impaired touch localization', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507805, 'HP:0011811', 'Impaired touch localization', 'MP:0011270', 'decreased excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507806, 'HP:0011811', 'Impaired touch localization', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507807, 'HP:0011811', 'Impaired touch localization', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507808, 'HP:0011811', 'Impaired touch localization', 'MP:0021016', 'decreased tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507809, 'HP:0011811', 'Impaired touch localization', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507810, 'HP:0011811', 'Impaired touch localization', 'MP:0011397', 'endoneurial edema', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507811, 'HP:0011811', 'Impaired touch localization', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507812, 'HP:0011811', 'Impaired touch localization', 'MP:0002910', 'abnormal excitatory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507813, 'HP:0011811', 'Impaired touch localization', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507814, 'HP:0011811', 'Impaired touch localization', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507815, 'HP:0011811', 'Impaired touch localization', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507816, 'HP:0011811', 'Impaired touch localization', 'MP:0010654', 'slow Wallerian degeneration', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507817, 'HP:0011811', 'Impaired touch localization', 'MP:0012555', 'decreased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507818, 'HP:0011811', 'Impaired touch localization', 'MP:0005087', 'decreased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507819, 'HP:0011811', 'Impaired touch localization', 'MP:0020218', 'abnormal tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507820, 'HP:0011811', 'Impaired touch localization', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507821, 'HP:0011811', 'Impaired touch localization', 'MP:0004142', 'abnormal muscle tone', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507822, 'HP:0011811', 'Impaired touch localization', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507823, 'HP:0011811', 'Impaired touch localization', 'MP:0013208', 'abnormal cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507824, 'HP:0011811', 'Impaired touch localization', 'MP:0002500', 'granulomatous inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507825, 'HP:0011811', 'Impaired touch localization', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507826, 'HP:0011811', 'Impaired touch localization', 'MP:0004753', 'abnormal miniature excitatory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507827, 'HP:0011811', 'Impaired touch localization', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507828, 'HP:0011811', 'Impaired touch localization', 'MP:0003486', 'abnormal channel response intensity', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507829, 'HP:0011811', 'Impaired touch localization', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507830, 'HP:0011811', 'Impaired touch localization', 'MP:0031170', 'abnormal vasculature physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507831, 'HP:0011811', 'Impaired touch localization', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507832, 'HP:0011811', 'Impaired touch localization', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507833, 'HP:0011811', 'Impaired touch localization', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507834, 'HP:0011811', 'Impaired touch localization', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507835, 'HP:0011811', 'Impaired touch localization', 'MP:0030991', 'optic nerve inflammation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507836, 'HP:0011811', 'Impaired touch localization', 'MP:0008776', 'increased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507837, 'HP:0011811', 'Impaired touch localization', 'MP:0002896', 'abnormal bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507838, 'HP:0011811', 'Impaired touch localization', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507839, 'HP:0011811', 'Impaired touch localization', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507840, 'HP:0011811', 'Impaired touch localization', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507841, 'HP:0011811', 'Impaired touch localization', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507842, 'HP:0011811', 'Impaired touch localization', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507843, 'HP:0011811', 'Impaired touch localization', 'MP:0002064', 'seizures', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507844, 'HP:0011811', 'Impaired touch localization', 'MP:0001793', 'abnormal susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507845, 'HP:0011811', 'Impaired touch localization', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507846, 'HP:0011811', 'Impaired touch localization', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507847, 'HP:0011811', 'Impaired touch localization', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507848, 'HP:0011811', 'Impaired touch localization', 'MP:0011925', 'abnormal heart echocardiography feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507849, 'HP:0011811', 'Impaired touch localization', 'MP:0004494', 'abnormal synaptic glutamate release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507850, 'HP:0011811', 'Impaired touch localization', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507851, 'HP:0011811', 'Impaired touch localization', 'MP:0002913', 'abnormal PNS synaptic transmission', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507852, 'HP:0011811', 'Impaired touch localization', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507853, 'HP:0011811', 'Impaired touch localization', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507854, 'HP:0011811', 'Impaired touch localization', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507855, 'HP:0011811', 'Impaired touch localization', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507856, 'HP:0011811', 'Impaired touch localization', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507857, 'HP:0011811', 'Impaired touch localization', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507858, 'HP:0011811', 'Impaired touch localization', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507859, 'HP:0011811', 'Impaired touch localization', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507860, 'HP:0011811', 'Impaired touch localization', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507861, 'HP:0011811', 'Impaired touch localization', 'MP:0001845', 'abnormal inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507862, 'HP:0011811', 'Impaired touch localization', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507863, 'HP:0011811', 'Impaired touch localization', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507864, 'HP:0011811', 'Impaired touch localization', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507865, 'HP:0011811', 'Impaired touch localization', 'MP:0003476', 'decreased summary potential intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507866, 'HP:0011811', 'Impaired touch localization', 'MP:0002945', 'abnormal inhibitory postsynaptic currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507867, 'HP:0011811', 'Impaired touch localization', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507868, 'HP:0011811', 'Impaired touch localization', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507869, 'HP:0011811', 'Impaired touch localization', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507870, 'HP:0011811', 'Impaired touch localization', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507871, 'HP:0011811', 'Impaired touch localization', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507872, 'HP:0011811', 'Impaired touch localization', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507873, 'HP:0011811', 'Impaired touch localization', 'MP:0001337', 'dry eyes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507874, 'HP:0011811', 'Impaired touch localization', 'MP:0000243', 'myoclonus', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507875, 'HP:0011811', 'Impaired touch localization', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507876, 'HP:0011811', 'Impaired touch localization', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507877, 'HP:0011811', 'Impaired touch localization', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507878, 'HP:0011811', 'Impaired touch localization', 'MP:0021010', 'impaired synaptic physiology', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507879, 'HP:0011811', 'Impaired touch localization', 'MP:0021013', 'abnormal synaptic vesicle endocytosis', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507880, 'HP:0011811', 'Impaired touch localization', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507881, 'HP:0011811', 'Impaired touch localization', 'MP:0002885', 'abnormal AMPA-mediated synaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507882, 'HP:0011811', 'Impaired touch localization', 'MP:0008722', 'abnormal chemokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507883, 'HP:0011811', 'Impaired touch localization', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507884, 'HP:0011811', 'Impaired touch localization', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507885, 'HP:0011811', 'Impaired touch localization', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507886, 'HP:0011811', 'Impaired touch localization', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507887, 'HP:0011811', 'Impaired touch localization', 'MP:0003220', 'decreased spike-wave discharge type II', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507888, 'HP:0011811', 'Impaired touch localization', 'MP:0004183', 'abnormal sympathetic nervous system physiology', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507889, 'HP:0011811', 'Impaired touch localization', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507890, 'HP:0011811', 'Impaired touch localization', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507891, 'HP:0011811', 'Impaired touch localization', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507892, 'HP:0011811', 'Impaired touch localization', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507893, 'HP:0011811', 'Impaired touch localization', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507894, 'HP:0011811', 'Impaired touch localization', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507895, 'HP:0011811', 'Impaired touch localization', 'MP:0002916', 'increased synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507896, 'HP:0011811', 'Impaired touch localization', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507897, 'HP:0011811', 'Impaired touch localization', 'MP:0005001', 'abnormal clonal deletion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507898, 'HP:0011811', 'Impaired touch localization', 'MP:0003823', 'increased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507899, 'HP:0011811', 'Impaired touch localization', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507900, 'HP:0011811', 'Impaired touch localization', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507901, 'HP:0011811', 'Impaired touch localization', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507902, 'HP:0011811', 'Impaired touch localization', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507903, 'HP:0011811', 'Impaired touch localization', 'MP:0020371', 'abnormal glymphatic system physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507904, 'HP:0011811', 'Impaired touch localization', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507905, 'HP:0011811', 'Impaired touch localization', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507906, 'HP:0011811', 'Impaired touch localization', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507907, 'HP:0011811', 'Impaired touch localization', 'MP:0009046', 'muscle twitch', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507908, 'HP:0011811', 'Impaired touch localization', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507909, 'HP:0011811', 'Impaired touch localization', 'MP:0003473', 'decreased summary potential threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507910, 'HP:0011811', 'Impaired touch localization', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507911, 'HP:0011811', 'Impaired touch localization', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507912, 'HP:0011811', 'Impaired touch localization', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507913, 'HP:0011811', 'Impaired touch localization', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507914, 'HP:0011811', 'Impaired touch localization', 'MP:0003039', 'increased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507915, 'HP:0011811', 'Impaired touch localization', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507916, 'HP:0011811', 'Impaired touch localization', 'MP:0011926', 'abnormal heart valve physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507917, 'HP:0011811', 'Impaired touch localization', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507918, 'HP:0011811', 'Impaired touch localization', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507919, 'HP:0011811', 'Impaired touch localization', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507920, 'HP:0011811', 'Impaired touch localization', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507921, 'HP:0011811', 'Impaired touch localization', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507922, 'HP:0011811', 'Impaired touch localization', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507923, 'HP:0011811', 'Impaired touch localization', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507924, 'HP:0011811', 'Impaired touch localization', 'MP:0003725', 'increased autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507925, 'HP:0011811', 'Impaired touch localization', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507926, 'HP:0011811', 'Impaired touch localization', 'MP:0002204', 'abnormal synaptic neurotransmitter level', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507927, 'HP:0011811', 'Impaired touch localization', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507928, 'HP:0011811', 'Impaired touch localization', 'MP:0003483', 'decreased nerve fiber response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507929, 'HP:0011811', 'Impaired touch localization', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507930, 'HP:0011811', 'Impaired touch localization', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507931, 'HP:0011811', 'Impaired touch localization', 'MP:0000950', 'abnormal seizure response to pharmacological agent', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507932, 'HP:0011811', 'Impaired touch localization', 'MP:0012504', 'increased forebrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507933, 'HP:0011811', 'Impaired touch localization', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507934, 'HP:0011811', 'Impaired touch localization', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507935, 'HP:0011811', 'Impaired touch localization', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507936, 'HP:0011811', 'Impaired touch localization', 'MP:0004768', 'abnormal axonal transport', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507937, 'HP:0011811', 'Impaired touch localization', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507938, 'HP:0011811', 'Impaired touch localization', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507939, 'HP:0011811', 'Impaired touch localization', 'MP:0005004', 'abnormal lymphocyte anergy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507940, 'HP:0011811', 'Impaired touch localization', 'MP:0005088', 'increased acute inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507941, 'HP:0011811', 'Impaired touch localization', 'MP:0002328', 'abnormal airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507942, 'HP:0011811', 'Impaired touch localization', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507943, 'HP:0011811', 'Impaired touch localization', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507944, 'HP:0011811', 'Impaired touch localization', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507945, 'HP:0011811', 'Impaired touch localization', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507946, 'HP:0011811', 'Impaired touch localization', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507947, 'HP:0011811', 'Impaired touch localization', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507948, 'HP:0011811', 'Impaired touch localization', 'MP:0011918', 'abnormal PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507949, 'HP:0011811', 'Impaired touch localization', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507950, 'HP:0011811', 'Impaired touch localization', 'MP:0010746', 'abnormal pre-Botzinger complex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507951, 'HP:0011811', 'Impaired touch localization', 'MP:0004149', 'increased bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507952, 'HP:0011811', 'Impaired touch localization', 'MP:0001984', 'abnormal olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507953, 'HP:0011811', 'Impaired touch localization', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507954, 'HP:0011811', 'Impaired touch localization', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507955, 'HP:0011811', 'Impaired touch localization', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507956, 'HP:0011811', 'Impaired touch localization', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507957, 'HP:0011811', 'Impaired touch localization', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507958, 'HP:0011811', 'Impaired touch localization', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507959, 'HP:0011811', 'Impaired touch localization', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507960, 'HP:0011811', 'Impaired touch localization', 'MP:0011953', 'prolonged PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507961, 'HP:0011811', 'Impaired touch localization', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507962, 'HP:0011811', 'Impaired touch localization', 'MP:0002194', 'maximal tonic hindlimb extension seizures', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507963, 'HP:0011811', 'Impaired touch localization', 'MP:0003880', 'abnormal central pattern generator function', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507964, 'HP:0011811', 'Impaired touch localization', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507965, 'HP:0011811', 'Impaired touch localization', 'MP:0009732', 'ventricular premature beat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507966, 'HP:0011811', 'Impaired touch localization', 'MP:0005447', 'abnormal synaptic norepinephrine release', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507967, 'HP:0011811', 'Impaired touch localization', 'MP:0003474', 'abnormal summary potential intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507968, 'HP:0011811', 'Impaired touch localization', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507969, 'HP:0011811', 'Impaired touch localization', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507970, 'HP:0011811', 'Impaired touch localization', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507971, 'HP:0011811', 'Impaired touch localization', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507972, 'HP:0011811', 'Impaired touch localization', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507973, 'HP:0011811', 'Impaired touch localization', 'MP:0011068', 'abnormal ependyma motile cilium physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507974, 'HP:0011811', 'Impaired touch localization', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507975, 'HP:0011811', 'Impaired touch localization', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507976, 'HP:0011811', 'Impaired touch localization', 'MP:0031332', 'abnormal inhibitory postsynaptic current amplitude', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507977, 'HP:0011811', 'Impaired touch localization', 'MP:0009358', 'environmentally induced seizures', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507978, 'HP:0011811', 'Impaired touch localization', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507979, 'HP:0011811', 'Impaired touch localization', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507980, 'HP:0011811', 'Impaired touch localization', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507981, 'HP:0011811', 'Impaired touch localization', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507982, 'HP:0011811', 'Impaired touch localization', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507983, 'HP:0011811', 'Impaired touch localization', 'MP:0010381', 'abnormal dosage compensation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507984, 'HP:0011811', 'Impaired touch localization', 'MP:0010071', 'abnormal pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507985, 'HP:0011811', 'Impaired touch localization', 'MP:0000231', 'hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507986, 'HP:0011811', 'Impaired touch localization', 'MP:0004513', 'avnosmia', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507987, 'HP:0011811', 'Impaired touch localization', 'MP:0021015', 'increased tau protein phosphorylation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507988, 'HP:0011811', 'Impaired touch localization', 'MP:0021001', 'impaired neuron physiology', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507989, 'HP:0011811', 'Impaired touch localization', 'MP:0008568', 'abnormal interleukin secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507990, 'HP:0011811', 'Impaired touch localization', 'MP:0010553', 'prolonged HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507991, 'HP:0011811', 'Impaired touch localization', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507992, 'HP:0011811', 'Impaired touch localization', 'MP:0004008', 'abnormal GABA-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507993, 'HP:0011811', 'Impaired touch localization', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507994, 'HP:0011811', 'Impaired touch localization', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507995, 'HP:0011811', 'Impaired touch localization', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507996, 'HP:0011811', 'Impaired touch localization', 'MP:0001800', 'abnormal humoral immune response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507997, 'HP:0011811', 'Impaired touch localization', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(507998, 'HP:0011811', 'Impaired touch localization', 'MP:0002886', 'abnormal glutamate-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(507999, 'HP:0011811', 'Impaired touch localization', 'MP:0020001', 'decreased response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508000, 'HP:0011811', 'Impaired touch localization', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508001, 'HP:0011811', 'Impaired touch localization', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508002, 'HP:0011811', 'Impaired touch localization', 'MP:0003487', 'increased channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508003, 'HP:0011811', 'Impaired touch localization', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508004, 'HP:0011811', 'Impaired touch localization', 'MP:0011268', 'biphasic excitatory postsynaptic current amplitude', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508005, 'HP:0011811', 'Impaired touch localization', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508006, 'HP:0011811', 'Impaired touch localization', 'MP:0004495', 'decreased synaptic glutamate release', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508007, 'HP:0011811', 'Impaired touch localization', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508008, 'HP:0011811', 'Impaired touch localization', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508009, 'HP:0011811', 'Impaired touch localization', 'MP:0009384', 'cardiac valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508010, 'HP:0011811', 'Impaired touch localization', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508011, 'HP:0011811', 'Impaired touch localization', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508012, 'HP:0011811', 'Impaired touch localization', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508013, 'HP:0011811', 'Impaired touch localization', 'MP:0031302', 'syncope', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508014, 'HP:0011811', 'Impaired touch localization', 'MP:0002917', 'decreased synaptic depression', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508015, 'HP:0011811', 'Impaired touch localization', 'MP:0011272', 'short excitatory postsynaptic current rise time', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508016, 'HP:0011811', 'Impaired touch localization', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508017, 'HP:0011811', 'Impaired touch localization', 'MP:0001837', 'defective assembly of class I molecules', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508018, 'HP:0011811', 'Impaired touch localization', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508019, 'HP:0011811', 'Impaired touch localization', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508020, 'HP:0011811', 'Impaired touch localization', 'MP:0005403', 'abnormal nerve conduction', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508021, 'HP:0011811', 'Impaired touch localization', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508022, 'HP:0011811', 'Impaired touch localization', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508023, 'HP:0011811', 'Impaired touch localization', 'MP:0009698', 'heart hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508024, 'HP:0011811', 'Impaired touch localization', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508025, 'HP:0011811', 'Impaired touch localization', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508026, 'HP:0011811', 'Impaired touch localization', 'MP:0003762', 'abnormal immune organ physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508027, 'HP:0011811', 'Impaired touch localization', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508028, 'HP:0011811', 'Impaired touch localization', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508029, 'HP:0011811', 'Impaired touch localization', 'MP:0001844', 'autoimmune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508030, 'HP:0011811', 'Impaired touch localization', 'MP:0013625', 'increased femur yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508031, 'HP:0011811', 'Impaired touch localization', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508032, 'HP:0011811', 'Impaired touch localization', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508033, 'HP:0011811', 'Impaired touch localization', 'MP:0031221', 'abnormal CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508034, 'HP:0011811', 'Impaired touch localization', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508035, 'HP:0011811', 'Impaired touch localization', 'MP:0010653', 'abnormal Wallerian degeneration', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508036, 'HP:0011811', 'Impaired touch localization', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508037, 'HP:0011811', 'Impaired touch localization', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508038, 'HP:0011811', 'Impaired touch localization', 'MP:0005623', 'abnormal meninges morphology', 0.4074074074074074, 4.0017449178869, 1.2768478852635776, 'UPHENO:0004523', 'abnormal nervous system'),
(508039, 'HP:0011811', 'Impaired touch localization', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508040, 'HP:0011811', 'Impaired touch localization', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508041, 'HP:0011811', 'Impaired touch localization', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508042, 'HP:0011811', 'Impaired touch localization', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508043, 'HP:0011811', 'Impaired touch localization', 'MP:0001596', 'hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508044, 'HP:0011811', 'Impaired touch localization', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508045, 'HP:0011811', 'Impaired touch localization', 'MP:0010571', 'shortened ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508046, 'HP:0011811', 'Impaired touch localization', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508047, 'HP:0011811', 'Impaired touch localization', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508048, 'HP:0011811', 'Impaired touch localization', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508049, 'HP:0011811', 'Impaired touch localization', 'MP:0006265', 'increased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508050, 'HP:0011811', 'Impaired touch localization', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508051, 'HP:0011811', 'Impaired touch localization', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508052, 'HP:0011811', 'Impaired touch localization', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508053, 'HP:0011811', 'Impaired touch localization', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508054, 'HP:0011811', 'Impaired touch localization', 'MP:0002471', 'abnormal complement pathway', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508055, 'HP:0011811', 'Impaired touch localization', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508056, 'HP:0011811', 'Impaired touch localization', 'MP:0006059', 'decreased susceptibility to ischemic brain injury', 0.5, 7.291997705654976, 1.9094498822507722, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508057, 'HP:0011811', 'Impaired touch localization', 'MP:0002887', 'decreased susceptibility to pharmacologically induced seizures', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508058, 'HP:0011811', 'Impaired touch localization', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508059, 'HP:0011811', 'Impaired touch localization', 'MP:0011929', 'abnormal aortic valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508060, 'HP:0011811', 'Impaired touch localization', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508061, 'HP:0011811', 'Impaired touch localization', 'MP:0002914', 'abnormal endplate potential', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508062, 'HP:0011811', 'Impaired touch localization', 'MP:0006080', 'brain ischemia', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508063, 'HP:0011811', 'Impaired touch localization', 'MP:0020155', 'enhanced humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508064, 'HP:0011811', 'Impaired touch localization', 'MP:0013752', 'stridor', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508065, 'HP:0011811', 'Impaired touch localization', 'MP:0002499', 'chronic inflammation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508066, 'HP:0011811', 'Impaired touch localization', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508067, 'HP:0011811', 'Impaired touch localization', 'MP:0002888', 'abnormal NMDA-mediated synaptic currents', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508068, 'HP:0011811', 'Impaired touch localization', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508069, 'HP:0011811', 'Impaired touch localization', 'MP:0011003', 'reduced AMPA-mediated synaptic currents', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508070, 'HP:0011811', 'Impaired touch localization', 'MP:0002635', 'reduced sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508071, 'HP:0011811', 'Impaired touch localization', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508072, 'HP:0011811', 'Impaired touch localization', 'MP:0012503', 'increased midbrain apoptosis', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508073, 'HP:0011811', 'Impaired touch localization', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.5833333333333334, 7.291997705654976, 2.062441593912113, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508074, 'HP:0011811', 'Impaired touch localization', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508075, 'HP:0011811', 'Impaired touch localization', 'MP:0002920', 'decreased paired-pulse facilitation', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508076, 'HP:0011811', 'Impaired touch localization', 'MP:0014120', 'focal seizures', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508077, 'HP:0011811', 'Impaired touch localization', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508078, 'HP:0011811', 'Impaired touch localization', 'MP:0003469', 'decreased single cell response intensity', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508079, 'HP:0011811', 'Impaired touch localization', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508080, 'HP:0011811', 'Impaired touch localization', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508081, 'HP:0011811', 'Impaired touch localization', 'MP:0006060', 'increased cerebral infarct size', 0.4827586206896552, 7.291997705654976, 1.8762395248086334, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508082, 'HP:0011811', 'Impaired touch localization', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508083, 'HP:0011811', 'Impaired touch localization', 'MP:0004046', 'abnormal mitosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508084, 'HP:0011811', 'Impaired touch localization', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508085, 'HP:0011811', 'Impaired touch localization', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508086, 'HP:0011811', 'Impaired touch localization', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508087, 'HP:0011811', 'Impaired touch localization', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508088, 'HP:0011811', 'Impaired touch localization', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508089, 'HP:0011811', 'Impaired touch localization', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508090, 'HP:0011811', 'Impaired touch localization', 'MP:0009062', 'impaired lectin complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508091, 'HP:0011811', 'Impaired touch localization', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508092, 'HP:0011811', 'Impaired touch localization', 'MP:0003485', 'abnormal channel response threshold', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508093, 'HP:0011811', 'Impaired touch localization', 'MP:0010515', 'abnormal Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508094, 'HP:0011811', 'Impaired touch localization', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508095, 'HP:0011811', 'Impaired touch localization', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508096, 'HP:0011811', 'Impaired touch localization', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508097, 'HP:0011811', 'Impaired touch localization', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508098, 'HP:0011811', 'Impaired touch localization', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508099, 'HP:0011811', 'Impaired touch localization', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508100, 'HP:0011811', 'Impaired touch localization', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508101, 'HP:0011811', 'Impaired touch localization', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508102, 'HP:0011811', 'Impaired touch localization', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508103, 'HP:0011811', 'Impaired touch localization', 'MP:0009244', 'abnormal acid-activated cation-mediated receptor currents', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508104, 'HP:0011811', 'Impaired touch localization', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.5384615384615384, 7.291997705654976, 1.981529788583807, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508105, 'HP:0011811', 'Impaired touch localization', 'MP:0004558', 'delayed allantois development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508106, 'HP:0011811', 'Impaired touch localization', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508107, 'HP:0011811', 'Impaired touch localization', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508108, 'HP:0011811', 'Impaired touch localization', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508109, 'HP:0011811', 'Impaired touch localization', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508110, 'HP:0011811', 'Impaired touch localization', 'MP:0003889', 'enhanced sensorimotor gating', 0.56, 7.291997705654976, 2.0207718117508437, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508111, 'HP:0011811', 'Impaired touch localization', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508112, 'HP:0011811', 'Impaired touch localization', 'MP:0009967', 'abnormal neuron proliferation', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508113, 'HP:0011811', 'Impaired touch localization', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508114, 'HP:0011811', 'Impaired touch localization', 'MP:0003488', 'decreased channel response intensity', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508115, 'HP:0011811', 'Impaired touch localization', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508116, 'HP:0011811', 'Impaired touch localization', 'MP:0003088', 'abnormal prepulse inhibition', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508117, 'HP:0011811', 'Impaired touch localization', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508118, 'HP:0011811', 'Impaired touch localization', 'MP:0020424', 'increased kindling response', 0.4666666666666667, 7.291997705654976, 1.8447038414442, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508119, 'HP:0011811', 'Impaired touch localization', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508120, 'HP:0011811', 'Impaired touch localization', 'MP:0003466', 'decreased single cell response threshold', 0.5185185185185185, 7.291997705654976, 1.944488582475262, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508121, 'HP:0011811', 'Impaired touch localization', 'MP:0021025', 'increased cerebrospinal fluid amyloid beta 40 isoform level', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508122, 'HP:0011811', 'Impaired touch localization', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508123, 'HP:0011811', 'Impaired touch localization', 'MP:0030153', 'dental pulp inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508124, 'HP:0001905', 'Congenital thrombocytopenia', 'MP:0003179', 'thrombocytopenia', 0.5254237288135594, 14.285219173023913, 2.739670258408697, 'UPHENO:0085302', 'abnormally decreased number of platelet'),
(508125, 'HP:0001905', 'Congenital thrombocytopenia', 'MP:0011898', 'abnormal platelet cell number', 0.4642857142857143, 13.548253578857707, 2.508039192314174, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(508126, 'HP:0001905', 'Congenital thrombocytopenia', 'MP:0005505', 'thrombocytosis', 0.40625, 13.548253578857707, 2.34605584256022, 'UPHENO:0086049', 'abnormal number of anatomical enitites of type platelet'),
(508127, 'HP:0001905', 'Congenital thrombocytopenia', 'MP:0003714', 'absent platelets', 0.4492753623188406, 14.285219173023913, 2.533376604408505, 'UPHENO:0085302', 'abnormally decreased number of platelet'),
(508128, 'HP:0001905', 'Congenital thrombocytopenia', 'MP:0011182', 'decreased hematopoietic cell number', 0.43137254901960786, 9.892901750245153, 2.0657991783336036, 'UPHENO:0085371', 'abnormally decreased number of hematopoietic cell'),
(508129, 'HP:0001905', 'Congenital thrombocytopenia', 'MP:0002875', 'decreased erythrocyte cell number', 0.40298507462686567, 11.533898285880637, 2.155919493272948, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(508130, 'HP:0001905', 'Congenital thrombocytopenia', 'MP:0013661', 'abnormal myeloid cell number', 0.40384615384615385, 10.175301480945878, 2.0271300814957747, 'UPHENO:0086005', 'abnormal number of anatomical enitites of type myeloid cell'),
(508131, 'HP:0001905', 'Congenital thrombocytopenia', 'MP:0013662', 'decreased myeloid cell number', 0.46296296296296297, 11.533898285880637, 2.310793743488315, 'UPHENO:0085344', 'abnormally decreased number of myeloid cell'),
(508132, 'HP:0011526', 'Abnormality of lens shape', 'MP:0006225', 'ocular rupture', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508133, 'HP:0011526', 'Abnormality of lens shape', 'MP:0031316', 'lentiglobus', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(508134, 'HP:0011526', 'Abnormality of lens shape', 'MP:0006209', 'calcified intraocular region', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508135, 'HP:0011526', 'Abnormality of lens shape', 'MP:0001303', 'abnormal lens morphology', 0.4117647058823529, 10.410750055107773, 2.070453919906488, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(508136, 'HP:0011526', 'Abnormality of lens shape', 'MP:0001305', 'enlarged lens', 0.42857142857142855, 10.410750055107773, 2.1122854976583105, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(508137, 'HP:0011526', 'Abnormality of lens shape', 'MP:0002697', 'abnormal eye size', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508138, 'HP:0011526', 'Abnormality of lens shape', 'MP:0011495', 'abnormal head shape', 0.40816326530612246, 6.5236679405794336, 1.6317847923055813, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(508139, 'HP:0011526', 'Abnormality of lens shape', 'MP:0030071', 'abnormal face shape', 0.43137254901960786, 6.5236679405794336, 1.677537262920036, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(508140, 'HP:0011526', 'Abnormality of lens shape', 'MP:0003847', 'disorganized lens bow', 0.40384615384615385, 10.410750055107773, 2.0504490650608487, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(508141, 'HP:0011526', 'Abnormality of lens shape', 'MP:0001304', 'cataract', 0.4074074074074074, 10.410750055107773, 2.059470001995169, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(508142, 'HP:0011526', 'Abnormality of lens shape', 'MP:0031317', 'spherophakia', 0.42105263157894735, 10.410750055107773, 2.093674689968286, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(508143, 'HP:0011526', 'Abnormality of lens shape', 'MP:0001306', 'small lens', 0.42857142857142855, 10.410750055107773, 2.1122854976583105, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(508144, 'HP:0011526', 'Abnormality of lens shape', 'MP:0030045', 'abnormal forehead shape', 0.41509433962264153, 6.5236679405794336, 1.6455812455519228, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(508145, 'HP:0011526', 'Abnormality of lens shape', 'MP:0030074', 'coarse facial features', 0.4230769230769231, 6.5236679405794336, 1.6613287933085112, 'UPHENO:0082129', 'shape anatomical entity in independent continuant'),
(508146, 'HP:0011526', 'Abnormality of lens shape', 'MP:0008841', 'ruptured lens capsule', 0.42857142857142855, 10.410750055107773, 2.1122854976583105, 'UPHENO:0087578', 'abnormal lens of camera-type eye morphology'),
(508147, 'HP:0011526', 'Abnormality of lens shape', 'MP:0001319', 'irregularly shaped pupil', 0.4262295081967213, 8.423925443855504, 1.8948682273499597, 'UPHENO:0087597', 'abnormal anterior segment of eyeball morphology'),
(508148, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010758', 'increased right ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508149, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508150, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001633', 'poor circulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508151, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011931', 'abnormal pulmonary valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508152, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010552', 'abnormal HV interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508153, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508154, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003039', 'increased time of peak ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508155, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508156, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508157, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010505', 'abnormal T wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508158, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006047', 'aortic valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508159, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508160, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508161, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011952', 'decreased cardiac stroke volume', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508162, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011938', 'prolonged PP interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508163, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508164, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010520', 'sinoatrial block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508165, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508166, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006049', 'semilunar valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508167, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0000233', 'abnormal blood flow velocity', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508168, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0002164', 'abnormal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508169, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010509', 'decreased P wave amplitude', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508170, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003820', 'increased left ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508171, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011920', 'abnormal S wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508172, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004485', 'increased response of heart to induced stress', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508173, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004879', 'decreased systemic vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508174, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006266', 'decreased pulse pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508175, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508176, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508177, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010514', 'fragmented QRS complex', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508178, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003928', 'increased heart rate variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508179, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0005532', 'abnormal vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508180, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006265', 'increased pulse pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508181, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508182, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010631', 'increased Q wave amplitude', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508183, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031302', 'syncope', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508184, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006045', 'mitral valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508185, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004217', 'salt-sensitive hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508186, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020096', 'high mean heart rate adaptation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508187, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004085', 'abnormal heartbeat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508188, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010756', 'decreased right ventricle peak pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508189, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0002952', 'ventricular cardiomyopathy', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508190, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508191, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010504', 'abnormal RR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508192, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001914', 'hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508193, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011930', 'abnormal tricuspid valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508194, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003901', 'abnormal PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508195, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0002842', 'increased systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508196, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003929', 'decreased heart rate variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508197, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004486', 'decreased response of heart to induced stress', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508198, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010515', 'abnormal Q wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508199, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508200, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004877', 'abnormal systemic vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508201, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004216', 'salt-resistant hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508202, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003823', 'increased left ventricle developed pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508203, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011937', 'shortened PP interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508204, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003899', 'abnormal QT interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508205, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508206, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508207, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0002128', 'abnormal blood circulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508208, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020097', 'low mean heart rate adaptation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508209, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508210, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001596', 'hypotension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508211, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0008950', 'ventricular tachycardia', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508212, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010559', 'heart block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508213, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011919', 'abnormal R wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508214, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010393', 'shortened QRS complex duration', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508215, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004072', 'abnormal frontal plane axis', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508216, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006138', 'congestive heart failure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508217, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508218, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004011', 'decreased diastolic filling velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508219, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508220, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003233', 'prolonged QT interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508221, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001983', 'abnormal olfactory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508222, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0005333', 'decreased heart rate', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508223, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010519', 'atrioventricular block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508224, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508225, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011928', 'abnormal mitral valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508226, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508227, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003393', 'decreased cardiac output', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508228, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003547', 'abnormal pulmonary pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508229, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010680', 'abnormal skin adnexa physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508230, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508231, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010695', 'abnormal blood pressure regulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508232, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006046', 'atrioventricular valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508233, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004122', 'abnormal sinus arrhythmia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508234, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010636', 'bundle branch block', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508235, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508236, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031170', 'abnormal vasculature physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508237, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0005435', 'hemoperitoneum', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508238, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508239, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508240, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010637', 'sinus bradycardia', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508241, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001598', 'abnormal blood viscosity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508242, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508243, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003897', 'abnormal ST segment', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508244, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508245, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508246, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011927', 'abnormal cardiac valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508247, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010516', 'absent Q wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508248, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003900', 'shortened QT interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508249, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003034', 'increased pulmonary vascular resistance', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508250, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031130', 'right-to-left shunt', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508251, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003898', 'abnormal QRS complex', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508252, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508253, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508254, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508255, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010511', 'shortened PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508256, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508257, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011929', 'abnormal aortic valve flow', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508258, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508259, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0009698', 'heart hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508260, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0013135', 'poor circulation in tail', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508261, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011953', 'prolonged PQ interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508262, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508263, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508264, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508265, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004070', 'abnormal P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508266, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006114', 'cardiac murmur', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508267, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0008776', 'increased right ventricle peak pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508268, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508269, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0008817', 'hematoma', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508270, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010560', 'intraventricular block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508271, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0000343', 'abnormal response to cardiac infarction', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508272, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508273, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508274, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508275, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010512', 'absent PR interval', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508276, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010394', 'decreased QRS amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508277, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508278, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508279, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508280, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508281, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006044', 'tricuspid valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508282, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010510', 'absent P wave', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508283, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004010', 'increased diastolic filling velocity', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508284, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508285, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508286, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010553', 'prolonged HV interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508287, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003824', 'decreased left ventricle developed pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508288, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508289, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010634', 'increased QRS amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508290, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001634', 'internal hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508291, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001985', 'abnormal gustatory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508292, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0009384', 'cardiac valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508293, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0000249', 'abnormal blood vessel physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508294, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001636', 'irregular heartbeat', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508295, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003394', 'increased cardiac output', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508296, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0013134', 'poor circulation in autopods', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508297, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031192', 'coronary artery spasm', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508298, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508299, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0002626', 'increased heart rate', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508300, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004156', 'abnormal QT variability', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508301, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006048', 'pulmonary valve regurgitation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508302, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031128', 'cardiovascular shunt', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508303, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001627', 'abnormal cardiac output', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508304, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010554', 'shortened HV interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508305, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003882', 'abnormal pulse pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508306, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001629', 'abnormal heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508307, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011918', 'abnormal PQ interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508308, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010571', 'shortened ST segment', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508309, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508310, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508311, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0000231', 'hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508312, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0012045', 'increased susceptibility to hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508313, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0031129', 'left-to-right shunt', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508314, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508315, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011954', 'shortened PQ interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508316, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010513', 'abnormal ventricular activation time', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508317, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0009732', 'ventricular premature beat', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508318, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004012', 'increased pulmonary artery pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508319, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004484', 'abnormal response of heart to induced stress', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508320, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508321, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0009275', 'bruising', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508322, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0004878', 'increased systemic vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508323, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011951', 'increased cardiac stroke volume', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508324, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0010570', 'prolonged ST segment', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508325, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011936', 'abnormal PP interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508326, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0012046', 'decreased susceptibility to hypertension', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508327, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0005330', 'cardiomyopathy', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508328, 'HP:0011688', 'Supraventricular tachycardia with an accessory connection mediated pathway', 'MP:0011926', 'abnormal heart valve physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(508329, 'HP:0034228', 'Proximal aortic arch hypoplasia', 'MP:0010474', 'descending aorta hypoplasia', 0.43859649122807015, 9.58108497132508, 2.049934206403019, 'UPHENO:0076809', 'abnormal aorta morphology'),
(508330, 'HP:0034228', 'Proximal aortic arch hypoplasia', 'MP:0010541', 'aorta hypoplasia', 0.45454545454545453, 9.58108497132508, 2.0868729293681447, 'UPHENO:0076809', 'abnormal aorta morphology'),
(508331, 'HP:0034228', 'Proximal aortic arch hypoplasia', 'MP:0010485', 'aortic arch hypoplasia', 0.5178571428571429, 15.607147267911275, 2.842933817785985, 'UPHENO:0081085', 'arch of aorta hypoplasia'),
(508332, 'HP:0034228', 'Proximal aortic arch hypoplasia', 'MP:0010543', 'aorta tubular hypoplasia', 0.44642857142857145, 9.58108497132508, 2.068156202148283, 'UPHENO:0076809', 'abnormal aorta morphology'),
(508333, 'HP:0034228', 'Proximal aortic arch hypoplasia', 'MP:0010458', 'pulmonary trunk hypoplasia', 0.41818181818181815, 8.202005804774931, 1.852006938480147, 'UPHENO:0081790', 'anatomical entity hypoplasia in independent continuant'),
(508334, 'HP:0034228', 'Proximal aortic arch hypoplasia', 'MP:0010460', 'pulmonary artery hypoplasia', 0.42857142857142855, 9.15319077934013, 1.9806049702776742, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(508335, 'HP:0034228', 'Proximal aortic arch hypoplasia', 'MP:0010528', 'pulmonary vein hypoplasia', 0.42105263157894735, 9.15319077934013, 1.9631543660612423, 'UPHENO:0076765', 'abnormal great vessel of heart morphology'),
(508336, 'HP:0034228', 'Proximal aortic arch hypoplasia', 'MP:0010469', 'ascending aorta hypoplasia', 0.4482758620689655, 11.562753148552822, 2.276686876924045, 'UPHENO:0087172', 'abnormal thoracic aorta morphology'),
(508337, 'HP:0011475', 'Persistent stapedial artery', 'MP:0003330', 'abnormal auditory tube morphology', 0.43902439024390244, 10.512629669126985, 2.1483251221238446, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508338, 'HP:0011475', 'Persistent stapedial artery', 'MP:0020900', 'abnormal middle ear epithelium morphology', 0.43902439024390244, 10.512629669126985, 2.1483251221238446, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508339, 'HP:0011475', 'Persistent stapedial artery', 'MP:0008863', 'craniofacial asymmetry', 0.4146341463414634, 4.6730878730104815, 1.3919848422322514, 'UPHENO:0087907', 'abnormal head morphology'),
(508340, 'HP:0011475', 'Persistent stapedial artery', 'MP:0000018', 'small ears', 0.41304347826086957, 7.8051695233081215, 1.7955150704805904, 'UPHENO:0076730', 'abnormal ear morphology'),
(508341, 'HP:0011475', 'Persistent stapedial artery', 'MP:0020901', 'abnormal middle ear goblet cell morphology', 0.42, 10.512629669126985, 2.1012625873586894, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508342, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030414', 'tympanic membrane perforation', 0.4666666666666667, 10.512629669126985, 2.214925246050664, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508343, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030321', 'abnormal tegmen tympani morphology', 0.42857142857142855, 10.512629669126985, 2.122595749392742, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508344, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030160', 'abnormal auditory bulla morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(508345, 'HP:0011475', 'Persistent stapedial artery', 'MP:0000049', 'abnormal middle ear morphology', 0.46153846153846156, 10.512629669126985, 2.2027217082991797, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508346, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030226', 'middle ear polyps', 0.45, 10.512629669126985, 2.1750134140062545, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508347, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030228', 'absent tubotympanic recess', 0.43902439024390244, 10.512629669126985, 2.1483251221238446, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508348, 'HP:0011475', 'Persistent stapedial artery', 'MP:0006018', 'abnormal tympanic membrane morphology', 0.42857142857142855, 10.512629669126985, 2.122595749392742, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508349, 'HP:0011475', 'Persistent stapedial artery', 'MP:0002102', 'abnormal ear morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(508350, 'HP:0011475', 'Persistent stapedial artery', 'MP:0011495', 'abnormal head shape', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(508351, 'HP:0011475', 'Persistent stapedial artery', 'MP:0003938', 'abnormal ear development', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(508352, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030413', 'tympanic membrane retraction', 0.4186046511627907, 10.512629669126985, 2.0977692140577586, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508353, 'HP:0011475', 'Persistent stapedial artery', 'MP:0000022', 'abnormal ear shape', 0.41304347826086957, 7.8051695233081215, 1.7955150704805904, 'UPHENO:0076730', 'abnormal ear morphology'),
(508354, 'HP:0011475', 'Persistent stapedial artery', 'MP:0000017', 'big ears', 0.41304347826086957, 7.8051695233081215, 1.7955150704805904, 'UPHENO:0076730', 'abnormal ear morphology'),
(508355, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030154', 'abnormal tympanic cavity morphology', 0.43902439024390244, 10.512629669126985, 2.1483251221238446, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508356, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030187', 'abnormal epitympanic recess morphology', 0.42857142857142855, 10.512629669126985, 2.122595749392742, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508357, 'HP:0011475', 'Persistent stapedial artery', 'MP:0011496', 'abnormal head size', 0.4358974358974359, 4.6730878730104815, 1.4272305425433802, 'UPHENO:0087907', 'abnormal head morphology'),
(508358, 'HP:0011475', 'Persistent stapedial artery', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.45, 10.512629669126985, 2.1750134140062545, 'UPHENO:0088067', 'abnormal middle ear morphology'),
(508359, 'HP:0010568', 'Hamartoma of the eye', 'MP:0001297', 'microphthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508360, 'HP:0010568', 'Hamartoma of the eye', 'MP:0031289', 'unilateral microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508361, 'HP:0010568', 'Hamartoma of the eye', 'MP:0001296', 'macrophthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508362, 'HP:0010568', 'Hamartoma of the eye', 'MP:0006248', 'lagophthalmos', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508363, 'HP:0010568', 'Hamartoma of the eye', 'MP:0006249', 'phthisis bulbi', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508364, 'HP:0010568', 'Hamartoma of the eye', 'MP:0010081', 'posterior microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508365, 'HP:0010568', 'Hamartoma of the eye', 'MP:0005176', 'eyelids fail to open', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508366, 'HP:0010568', 'Hamartoma of the eye', 'MP:0006225', 'ocular rupture', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508367, 'HP:0010568', 'Hamartoma of the eye', 'MP:0002697', 'abnormal eye size', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508368, 'HP:0010568', 'Hamartoma of the eye', 'MP:0031290', 'bilateral microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508369, 'HP:0010568', 'Hamartoma of the eye', 'MP:0003671', 'abnormal eyelid aperture', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(508370, 'HP:0010568', 'Hamartoma of the eye', 'MP:0006164', 'ectropion', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(508371, 'HP:0010568', 'Hamartoma of the eye', 'MP:0006209', 'calcified intraocular region', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508372, 'HP:0010568', 'Hamartoma of the eye', 'MP:0009274', 'buphthalmos', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(508373, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.41379310344827586, 7.390401409715969, 1.7487415861284032, 'UPHENO:0087427', 'abnormal renal system morphology'),
(508374, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0003675', 'kidney cyst', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508375, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0009641', 'kidney degeneration', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508376, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011383', 'abnormal kidney capsule morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508377, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0003197', 'nephrocalcinosis', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508378, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0012026', 'abnormal S-shaped body morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508379, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011333', 'abnormal kidney inner medulla morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508380, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011425', 'abnormal kidney interstitium morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508381, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0004969', 'pale kidney', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508382, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011347', 'abnormal kidney medullary ray morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508383, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0004192', 'abnormal kidney pyramid morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508384, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0002706', 'abnormal kidney size', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508385, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011364', 'abnormal metanephros morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508386, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0003985', 'renal fibrosis', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508387, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0002703', 'abnormal renal tubule morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508388, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0000521', 'abnormal kidney cortex morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508389, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011382', 'abnormal kidney lobule morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508390, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0008528', 'polycystic kidney', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508391, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0012025', 'abnormal comma shaped body morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508392, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0003613', 'abnormal kidney medulla development', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508393, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011402', 'renal cast', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508394, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0012024', 'abnormal nephron morphogenesis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508395, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0002955', 'increased compensatory renal growth', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508396, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0002829', 'abnormal juxtaglomerular apparatus morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508397, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0008487', 'abnormal mesonephros morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508398, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011337', 'abnormal perihilar interstitium morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508399, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011379', 'abnormal kidney outer medulla outer stripe morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508400, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0003881', 'abnormal nephron morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508401, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0002956', 'decreased compensatory renal growth', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508402, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011376', 'abnormal kidney corticomedullary boundary morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508403, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0000527', 'abnormal kidney development', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508404, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011381', 'abnormal kidney lobe morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508405, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0000534', 'abnormal ureter morphology', 0.40625, 7.390401409715969, 1.7327292265951748, 'UPHENO:0087427', 'abnormal renal system morphology'),
(508406, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011334', 'abnormal nephrogenic zone morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508407, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0004967', 'abnormal kidney epithelium morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508408, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011378', 'abnormal kidney outer medulla inner stripe morphology', 0.4166666666666667, 7.667568053596582, 1.787405947828279, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508409, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0004194', 'abnormal kidney pelvis morphology', 0.45454545454545453, 7.667568053596582, 1.8668846258353151, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508410, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0003014', 'abnormal kidney medulla morphology', 0.46875, 7.667568053596582, 1.8958302996638168, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508411, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0002135', 'abnormal kidney morphology', 0.5, 7.667568053596582, 1.9580051140889012, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508412, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0003600', 'ectopic kidney', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508413, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0004754', 'abnormal kidney collecting duct morphology', 0.40540540540540543, 7.667568053596582, 1.7630863663592482, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508414, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0009860', 'nephrosclerosis', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508415, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0004195', 'abnormal kidney calyx morphology', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508416, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011534', 'granular kidney', 0.4838709677419355, 7.667568053596582, 1.9261655106249116, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508417, 'HP:0032947', 'Renal medullary interstitial inflammation', 'MP:0011332', 'abnormal kidney outer medulla morphology', 0.4411764705882353, 7.667568053596582, 1.839225546767129, 'UPHENO:0076779', 'abnormal kidney morphology'),
(508418, 'HP:5200062', 'Auditory sensory seeking', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508419, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508420, 'HP:5200062', 'Auditory sensory seeking', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508421, 'HP:5200062', 'Auditory sensory seeking', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508422, 'HP:5200062', 'Auditory sensory seeking', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508423, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508424, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508425, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508426, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508427, 'HP:5200062', 'Auditory sensory seeking', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508428, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508429, 'HP:5200062', 'Auditory sensory seeking', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508430, 'HP:5200062', 'Auditory sensory seeking', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508431, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508432, 'HP:5200062', 'Auditory sensory seeking', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508433, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508434, 'HP:5200062', 'Auditory sensory seeking', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508435, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508436, 'HP:5200062', 'Auditory sensory seeking', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508437, 'HP:5200062', 'Auditory sensory seeking', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508438, 'HP:5200062', 'Auditory sensory seeking', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508439, 'HP:5200062', 'Auditory sensory seeking', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508440, 'HP:5200062', 'Auditory sensory seeking', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508441, 'HP:5200062', 'Auditory sensory seeking', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508442, 'HP:5200062', 'Auditory sensory seeking', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508443, 'HP:5200062', 'Auditory sensory seeking', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508444, 'HP:5200062', 'Auditory sensory seeking', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508445, 'HP:5200062', 'Auditory sensory seeking', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508446, 'HP:5200062', 'Auditory sensory seeking', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508447, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508448, 'HP:5200062', 'Auditory sensory seeking', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508449, 'HP:5200062', 'Auditory sensory seeking', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508450, 'HP:5200062', 'Auditory sensory seeking', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508451, 'HP:5200062', 'Auditory sensory seeking', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508452, 'HP:5200062', 'Auditory sensory seeking', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508453, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508454, 'HP:5200062', 'Auditory sensory seeking', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508455, 'HP:5200062', 'Auditory sensory seeking', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508456, 'HP:5200062', 'Auditory sensory seeking', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508457, 'HP:5200062', 'Auditory sensory seeking', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508458, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508459, 'HP:5200062', 'Auditory sensory seeking', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508460, 'HP:5200062', 'Auditory sensory seeking', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508461, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508462, 'HP:5200062', 'Auditory sensory seeking', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(508463, 'HP:0004570', 'Increased vertebral height', 'MP:0004602', 'abnormal vertebral articular process morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508464, 'HP:0004570', 'Increased vertebral height', 'MP:0008771', 'elongated vertebral column', 0.4090909090909091, 8.557298718460714, 1.8710192709049165, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(508465, 'HP:0004570', 'Increased vertebral height', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.4318181818181818, 8.941811350726098, 1.9650029820923236, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508466, 'HP:0004570', 'Increased vertebral height', 'MP:0003049', 'abnormal lumbar vertebrae morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508467, 'HP:0004570', 'Increased vertebral height', 'MP:0004705', 'elongated vertebral body', 0.4166666666666667, 10.93472192593978, 2.134510280089614, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(508468, 'HP:0004570', 'Increased vertebral height', 'MP:0013612', 'enlarged caudal vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508469, 'HP:0004570', 'Increased vertebral height', 'MP:0004657', 'small sacral vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508470, 'HP:0004570', 'Increased vertebral height', 'MP:0005227', 'abnormal vertebral body development', 0.4146341463414634, 10.93472192593978, 2.129297792992639, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(508471, 'HP:0004570', 'Increased vertebral height', 'MP:0004626', 'vertebral compression', 0.4222222222222222, 8.941811350726098, 1.943046952390874, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508472, 'HP:0004570', 'Increased vertebral height', 'MP:0003050', 'abnormal sacral vertebrae morphology', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508473, 'HP:0004570', 'Increased vertebral height', 'MP:0004670', 'small vertebral body', 0.45454545454545453, 10.93472192593978, 2.22942327702804, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(508474, 'HP:0004570', 'Increased vertebral height', 'MP:0005225', 'abnormal vertebrae development', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508475, 'HP:0004570', 'Increased vertebral height', 'MP:0013972', 'occipital vertebra', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508476, 'HP:0004570', 'Increased vertebral height', 'MP:0004707', 'enlarged lumbar vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508477, 'HP:0004570', 'Increased vertebral height', 'MP:0004610', 'small vertebrae', 0.4523809523809524, 8.941811350726098, 2.011244673045098, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508478, 'HP:0004570', 'Increased vertebral height', 'MP:0004643', 'abnormal vertebrae number', 0.4146341463414634, 8.941811350726098, 1.9255078073471226, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508479, 'HP:0004570', 'Increased vertebral height', 'MP:0000141', 'abnormal vertebral body morphology', 0.4473684210526316, 10.93472192593978, 2.2117525364871335, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(508480, 'HP:0004570', 'Increased vertebral height', 'MP:0004687', 'split vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508481, 'HP:0004570', 'Increased vertebral height', 'MP:0003036', 'vertebral transformation', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508482, 'HP:0004570', 'Increased vertebral height', 'MP:0004704', 'short vertebral column', 0.4090909090909091, 8.557298718460714, 1.8710192709049165, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(508483, 'HP:0004570', 'Increased vertebral height', 'MP:0004600', 'abnormal vertebral transverse process morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508484, 'HP:0004570', 'Increased vertebral height', 'MP:0004174', 'abnormal spine curvature', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(508485, 'HP:0004570', 'Increased vertebral height', 'MP:0021136', 'abnormal vertebrae shape', 0.4418604651162791, 8.941811350726098, 1.9877205342838962, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508486, 'HP:0004570', 'Increased vertebral height', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.4358974358974359, 8.941811350726098, 1.974262556009229, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508487, 'HP:0004570', 'Increased vertebral height', 'MP:0008832', 'hemivertebra', 0.42105263157894735, 8.941811350726098, 1.9403538853275515, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508488, 'HP:0004570', 'Increased vertebral height', 'MP:0031312', 'spondylolysis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(508489, 'HP:0004570', 'Increased vertebral height', 'MP:0004703', 'abnormal vertebral column morphology', 0.4166666666666667, 8.557298718460714, 1.8882640526928336, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(508490, 'HP:0004570', 'Increased vertebral height', 'MP:0031313', 'spondylolisthesis', 0.40540540540540543, 8.557298718460714, 1.86257218816687, 'UPHENO:0076695', 'abnormal vertebral column morphology'),
(508491, 'HP:0004570', 'Increased vertebral height', 'MP:0000137', 'abnormal vertebrae morphology', 0.43243243243243246, 8.941811350726098, 1.9664000693517127, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(508492, 'HP:0004570', 'Increased vertebral height', 'MP:0004706', 'short vertebral body', 0.40816326530612246, 10.93472192593978, 2.112617288224735, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(508493, 'HP:0004570', 'Increased vertebral height', 'MP:0004669', 'enlarged vertebral body', 0.46511627906976744, 10.93472192593978, 2.255197812799514, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(508494, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508495, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002405', 'respiratory system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508496, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508497, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508498, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508499, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0010950', 'abnormal lung hysteresivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508500, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508501, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508502, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508503, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508504, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0011764', 'ureteritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508505, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002164', 'abnormal gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508506, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508507, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508508, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508509, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001835', 'abnormal antigen presentation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508510, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508511, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508512, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508513, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003880', 'abnormal central pattern generator function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508514, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001819', 'abnormal immune cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508515, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0011717', 'increased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508516, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508517, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508518, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508519, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508520, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001756', 'abnormal urination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508521, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008676', 'decreased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508522, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008722', 'abnormal chemokine secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508523, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508524, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508525, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508526, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508527, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508528, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001866', 'nasal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508529, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0011082', 'abnormal gastrointestinal motility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508530, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508531, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508532, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508533, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508534, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508535, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508536, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005666', 'abnormal adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508537, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0010377', 'abnormal gut flora balance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508538, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508539, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508540, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002128', 'abnormal blood circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508541, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508542, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001919', 'abnormal reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508543, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508544, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508545, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008666', 'increased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508546, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508547, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508548, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508549, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003278', 'esophageal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508550, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508551, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508552, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508553, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508554, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508555, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0030153', 'dental pulp inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508556, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508557, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508558, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508559, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020142', 'increased anti-sperm antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508560, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0012382', 'abnormal blood cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508561, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008004', 'abnormal stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508562, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005076', 'abnormal cell differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508563, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508564, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008672', 'increased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508565, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508566, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508567, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508568, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508569, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008861', 'abnormal hair shedding', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508570, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508571, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003298', 'choking', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508572, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508573, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0009058', 'decreased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508574, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508575, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508576, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508577, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508578, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508579, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508580, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508581, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508582, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508583, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508584, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508585, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508586, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020002', 'increased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508587, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508588, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508589, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508590, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0013498', 'trachea inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508591, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508592, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508593, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508594, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003875', 'abnormal hair follicle regression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508595, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508596, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508597, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508598, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508599, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508600, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0031090', 'ageusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508601, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508602, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508603, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004751', 'increased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508604, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508605, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508606, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003566', 'abnormal cell adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508607, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508608, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508609, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005190', 'osteomyelitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508610, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0030132', 'periodontium inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508611, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508612, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508613, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508614, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508615, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001984', 'abnormal olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508616, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508617, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508618, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508619, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001837', 'defective assembly of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508620, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008703', 'decreased interleukin-5 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508621, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508622, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004212', 'abnormal salty taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508623, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508624, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002471', 'abnormal complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508625, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008679', 'decreased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508626, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003726', 'decreased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508627, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508628, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508629, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508630, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508631, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508632, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508633, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508634, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508635, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508636, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508637, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004752', 'decreased length of allograft survival', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508638, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508639, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508640, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508641, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(508642, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508643, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508644, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0031066', 'cytokine storm', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(508645, 'HP:0002724', 'Recurrent Aspergillus infections', 'MP:0001985', 'abnormal gustatory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
